Avago Technologies Inactive 10-Q10 Jun 142014 Q2 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information Document	6 Months Ended
Document and Entity Information Document	4-May-14	30-May-14
Entity Information [Line Items]	'	'
Entity Registrant Name	'Avago Technologies LTD	'
Entity Central Index Key	'0001441634	'
Current Fiscal Year End Date	'--11-02	'
Entity Filer Category	'Large Accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	4-May-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	251,717,174

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets - Unaudited (USD $)	4-May-14	Nov. 03, 2013
In Millions, unless otherwise specified	4-May-14	Nov. 03, 2013
Current assets:	'	'
Cash and cash equivalents	$1,278	$985	[1]
Trade accounts receivable, net	319	418	[1]
Inventory	301	285	[1]
Other current assets	136	130	[1]
Total current assets	2,034	1,818	[1]
Property, plant and equipment, net	731	661	[1]
Goodwill	392	391	[1]
Intangible Assets, Net	441	492	[1]
Other long-term assets	73	53	[1]
Total assets	3,671	3,415	[1]
Current liabilities:	'	'
Accounts payable	274	278	[1]
Employee compensation and benefits	86	98	[1]
Other current liabilities	56	47	[1]
Total current liabilities	416	423	[1]
Long-term liabilities:	'	'
Other long-term liabilities	101	106	[1]
Total liabilities	517	529	[1]
Commitments and contingencies (Note 12)	'	'	[1]
Shareholders' equity:	'	'
Ordinary shares, no par value; 251,328,239 shares and 249,100,178 shares issued and outstanding on May 4, 2014 and November 3, 2013, respectively	1,694	1,587	[1]
Retained earnings	1,467	1,305	[1]
Accumulated other comprehensive loss	-7	-6	[1]
Total shareholders' equity	3,154	2,886	[1]
Total liabilities and shareholders' equity	$3,671	$3,415	[1]

[1]	Amounts as of NovemberÂ 3, 2013 have been derived from audited consolidated financial statements as of that date.

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets - Unaudited Consolidated Balance Sheet (Parenthetical)	4-May-14	Nov. 03, 2013
Common Stock, Shares, Issued	251,328,239	249,100,178
Common Stock, Shares, Outstanding	251,328,239	249,100,178

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations - Unaudited (USD $)	3 Months Ended		6 Months Ended
In Millions, except Per Share data, unless otherwise specified	4-May-14	5-May-13	4-May-14	5-May-13
Net revenue	$701	$562	$1,410	$1,138
Cost of products sold:	'	'	'	'
Cost of products sold	326	276	673	562
Cost of Goods Sold, Amortization	18	14	36	28
Restructuring charges	0	0	5	0
Total cost of products sold	344	290	714	590
Gross margin	357	272	696	548
Research and development	114	95	221	188
Selling, general and administrative	67	52	141	105
Amortization of intangible assets	8	6	15	11
Restructuring charges	8	1	20	2
Total operating expenses	197	154	397	306
Income from operations	160	118	299	242
Interest Expense	-1	-1	-1	-1
Other income, net	0	1	0	3
Income before income taxes	159	118	298	244
Provision for income taxes	1	5	6	6
Net income	$158	$113	$292	$238
Net income per share:	'	'	'	'
Earnings Per Share, Basic	$0.63	$0.46	$1.17	$0.97
Earnings Per Share, Diluted	$0.61	$0.45	$1.14	$0.95
Weighted average shares :	'	'	'	'
Weighted Average Number of Shares Outstanding, Basic	251	246	250	246
Weighted Average Number of Shares Outstanding, Diluted	258	251	256	251
Cash dividends declared and paid per share	$0.27	$0.19	$0.52	$0.36

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income - Unaudited (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	4-May-14	5-May-13	4-May-14	5-May-13
Net income	$158	$113	$292	$238
Unrealized gains of post-retirement plan and defined benefit pension plans, net of tax	0	0	0	2
Other Comprehensive Income (Loss), Finalization of Pension and Other Postretirement Benefit Plan Valuation, Net of Tax	0	0	2	0
Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit) Arising During Period, Net of Tax	0	0	1	0
Change in net unrealized gain on available-for-sale investments	0	2	0	2
Other comprehensive income (loss)	0	2	-1	4
Total comprehensive income	$158	$115	$291	$242

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows - Unaudited (USD $)	6 Months Ended
In Millions, unless otherwise specified	4-May-14		5-May-13
Cash flows from operating activities:	'		'
Net income	$292		$238
Adjustments to reconcile net income to net cash provided by operating activities:	'		'
Depreciation and amortization	118		83
Share-based compensation	54		35
Gain (Loss) on Disposition of Property Plant Equipment	0		1
Unrealized (gain)/loss on trading securities	0		-1
Tax benefit from share-based compensation	12		0
Excess tax benefits from share-based compensation	-11		0
Defined Benefit Plan, Recognized Net Gain (Loss) Due to Settlements and Curtailments	-3		0
Changes in assets and liabilities, net of acquisitions:	'		'
Trade accounts receivable, net	99		70
Inventory	-16		-34
Accounts payable	16		-2
Employee compensation and benefits	12		2
Other current assets and current liabilities	-13		-21	[1]
Other long-term assets and long-term liabilities	24		-2
Net cash provided by operating activities	480		373	[1]
Cash flows from investing activities:	'		'
Purchases of property, plant and equipment	-125		-114
Proceeds from the sale of investment	14		0
Purchases of investments	0		-37
Acquisition, net of cash acquired	0		-9
Net cash used in investing activities	-111		-160
Cash flows from financing activities:	'		'
Payments on capital lease obligations	0		1
Proceeds from government grants	2		8	[1]
Issuance of ordinary shares	53		28
Repurchases of ordinary shares	-12		-24
Excess tax benefits from share-based compensation	11		0
Dividend payments to shareholders	-130		-89
Net cash used in financing activities	-76		-78	[1]
Net (decrease) increase in cash and cash equivalents	293		135
Cash and cash equivalents at the beginning of period	985	[2]	1,084
Cash and cash equivalents at end of period	$1,278		$1,219

[1]	(1) The statement of cash flows data for the two quarters ended May 5, 2013 reflects a reclassification of $3 million of government grant reimbursements related to fixed assets from cash flows provided by operating activities to cash flows used in financing activities. As a result, net cash provided by operating activities and net cash used in financing activities for this period each decreased by a corresponding amount.
[2]	Amounts as of NovemberÂ 3, 2013 have been derived from audited consolidated financial statements as of that date.

Overview_and_Basis_of_Presenta

Overview and Basis of Presentation	6 Months Ended
	4-May-14
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Overview and Basis of Presentation	'
	Overview, Basis of Presentation and Significant Accounting Policies
	Overview
	Avago Technologies Limited, or the “Company”, was organized under the laws of the Republic of Singapore in August 2005. We are a designer, developer and global supplier of semiconductor devices with a focus on III-V based products. Through the fiscal quarter ended May 4, 2014, we offered products in three primary target markets: wireless communications, wired infrastructure and industrial & other. Applications for our products in these target markets include cellular phones, consumer appliances, data networking and telecommunications equipment, enterprise storage and servers, factory automation and display. References herein to "the Company", "we", "our", "us" and "Avago" are to Avago Technologies Limited and its consolidated subsidiaries, unless otherwise specified or the context otherwise requires.
	Basis of Presentation
	Fiscal Periods. We operate on a 52- or 53-week fiscal year ending on the Sunday closest to October 31. Our fiscal year ending November 2, 2014, or fiscal year 2014, is a 52-week fiscal year. The first quarter of our fiscal year 2014 ended on February 2, 2014, the second quarter ended on May 4, 2014, the third quarter will end on August 3, 2014 and the fourth quarter will end on November 2, 2014. Our fiscal year ended November 3, 2013, or fiscal year 2013, was a 53-week fiscal year, with our first fiscal quarter containing 14 weeks.
	Information. The unaudited condensed consolidated financial statements include the accounts of Avago Technologies Limited and all of its wholly-owned subsidiaries, and are prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP. Intercompany transactions and balances have been eliminated in consolidation.
	During fiscal year 2013, we completed our acquisition of CyOptics, Inc., or CyOptics. The unaudited condensed consolidated financial statements include the results of operations of CyOptics commencing as of the closing date of the acquisition. (See Note 3. "Acquisitions and Investment")
	Interim information presented in the unaudited condensed consolidated financial statements has been prepared by management and, in the opinion of management, includes all adjustments of a normal recurring nature that are necessary for the fair statement of the financial position, results of operations, comprehensive income and cash flows for the periods shown, and is in accordance with GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the fiscal year ended November 3, 2013, or fiscal year 2013, included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission, or the SEC, on December 20, 2013.
	The operating results for the fiscal quarter and two fiscal quarters ended May 4, 2014 are not necessarily indicative of the results that may be expected for fiscal year 2014, or for any other future period. The balance sheet data as of November 3, 2013 presented are derived from the audited consolidated financial statements as of that date.
	Significant Accounting Policies
	Use of estimates. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, and such differences could affect the results of operations reported in future periods.
	Concentrations of credit risk and significant customers. Our cash, cash equivalents and accounts receivable are potentially subject to concentration of credit risk. Cash and cash equivalents may be redeemable upon demand and are maintained with several financial institutions that management believes are of high credit quality and therefore bear minimal credit risk. We seek to mitigate our credit risks by spreading such risks across multiple counterparties and monitoring the risk profile of these counterparties. Our accounts receivable are derived from revenue earned from customers located in the U.S. and internationally. We mitigate collection risks from our customers by performing regular credit evaluations of our customers' financial conditions, and require collateral, such as letters of credit and bank guarantees, in certain circumstances.
	We sell our products through our direct sales force, distributors and manufacturers' representatives. Two direct customers accounted for 19% and 10%, respectively, of our net accounts receivable balance at May 4, 2014. One direct customer accounted for 26% of our net accounts receivable balance at November 3, 2013. For the fiscal quarter ended May 4, 2014, two direct customers represented 14% and 13% of our net revenue, respectively. For the fiscal quarter ended May 5, 2013, two direct customers represented 16% and 10% of our net revenue, respectively. For the two fiscal quarters ended May 4, 2014, two direct customers represented 20% and 10% of our net revenue, respectively. For the two fiscal quarters ended May 5, 2013, one direct customer represented 18% of our net revenue.
	Warranty. We accrue for the estimated costs of product warranties at the time revenue is recognized. Product warranty costs are estimated based upon our historical experience and specific identification of product requirements, which may fluctuate based on product mix. Additionally, we accrue for warranty costs associated with occasional or unanticipated product quality issues if a loss is probable and can be reasonably estimated. Warranty costs were not material for either of the fiscal quarter or the two quarters ended May 4, 2014 or May 5, 2013.
	Net income per share. Basic net income per share is computed using the weighted-average number of ordinary shares outstanding during the period. Diluted net income per share is computed using the weighted-average number of ordinary shares and potentially dilutive share equivalents outstanding during the period. Diluted shares outstanding includes the dilutive effect of in-the-money options (including market-based share options), restricted share units, or RSUs, and employee share purchase rights under the Avago Technologies Limited Employee Share Purchase Plan, or ESPP. The dilutive effect of such equity awards is calculated based on the average share price for each fiscal period, using the treasury stock method. Under the treasury stock method, the amount the employee must pay for exercising share options and to purchase shares under the ESPP, the amount of compensation cost for future service that the Company has not yet recognized, and the amount of tax benefits that would be recorded in an ordinary shares account when equity awards become deductible for income tax purposes are collectively assumed to be used to repurchase ordinary shares.
	Diluted net income per share for the fiscal quarter and two fiscal quarters ended May 4, 2014 and the fiscal quarter and two fiscal quarters ended May 5, 2013 excluded the potentially dilutive effect of weighted-average outstanding equity awards (options, RSUs and ESPP rights) to acquire 1 million, 0 million, 2 million and 2 million ordinary shares, respectively, as their effect was antidilutive.
	The following is a reconciliation of the basic and diluted net income per share computations for the periods presented (in millions, except per share data):


		Fiscal Quarter Ended				Two Fiscal Quarters Ended
		May 4,		May 5,		May 4,		May 5,
		2014		2013		2014		2013
	Net income (Numerator):
	Net income	$	158	$	113	$	292	$	238

	Shares (Denominator):
	Basic weighted-average ordinary shares outstanding	251		246		250		246

	Add incremental shares for:
	Dilutive effect of share options, RSUs and ESPP rights	7		5		6		5

	Shares used in diluted computation	258		251		256		251

	Net income per share:
	Basic	$	0.63	$	0.46	$	1.17	$	0.97

	Diluted	$	0.61	$	0.45	$	1.14	$	0.95

	Supplemental cash flow disclosures. At May 4, 2014 and November 3, 2013, we had $43 million and $31 million, respectively, of unpaid purchases of property, plant, and equipment included in accounts payable and other current liabilities. Amounts reported as unpaid purchases will be recorded as cash outflows from investing activities for purchases of property, plant, and equipment in the unaudited condensed consolidated statement of cash flows for the period in which they are paid.
	Recently Adopted Accounting Guidance
	In the first quarter of fiscal year 2014, we adopted guidance issued by the Financial Accounting Standards Board, or FASB, relating to reporting on reclassifications out of accumulated other comprehensive income (loss). This guidance seeks to improve the reporting of such reclassifications by requiring an entity to report the effect of significant reclassifications out of accumulated other comprehensive income (loss) on the respective line items in net income if the amount being reclassified is required under GAAP to be reclassified in its entirety to net income. For other amounts that are not required under GAAP to be reclassified in their entirety to net income in the same reporting period, an entity is required to cross-reference other disclosures required under GAAP that provide additional detail about those amounts. The amendments in this guidance supersede the presentation requirements for reclassifications out of accumulated other comprehensive income (loss) in previously issued guidance. The adoption of this guidance affected the presentation of comprehensive income, but did not have any impact our financial condition or results of operations.
	Recent Accounting Guidance Not Yet Adopted
	In May 2014, the FASB and International Accounting Standards Board issued their converged standard on revenue recognition. The core principle of the new standard is for companies to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration (that is, payment) to which the company expects to be entitled in exchange for those goods or services. The new standard also will result in enhanced disclosures about revenue, provide guidance for transactions that were not previously addressed comprehensively (for example, service revenue and contract modifications) and improve guidance for multiple-element arrangements. This guidance will be effective for the first quarter of our fiscal year 2018. The Company is currently evaluating the impact that this guidance will have on its financial condition and results of operations.
	In April 2014, the FASB issued authoritative guidance that raises the threshold for a disposal transaction to qualify as a discontinued operation and requires additional disclosures about discontinued operations and disposals of individually significant components that do not qualify as discontinued operations. This guidance will be effective prospectively for the first quarter of our fiscal year 2016. Early adoption is permitted, but only for disposals that have not been reported in financial statements previously issued. The Company is evaluating the impact, if any, that this guidance will have on its financial condition or results of operations.
	In July 2013, the FASB issued an amendment to the accounting guidance related to the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists. The guidance requires an unrecognized tax benefit to be presented as a decrease in a deferred tax asset where a net operating loss, a similar tax loss or a tax credit carryforward exists and certain criteria are met. This guidance will be effective for the first quarter of our fiscal year 2015. The adoption of this guidance will affect the presentation of our unrecognized tax benefits but will not impact the Company's financial condition or results of operations.

Inventory

Inventory	6 Months Ended
	4-May-14
Inventory Disclosure [Abstract]	'
Inventory	'
	Inventory
	Inventory consists of the following (in millions):


		May 4, 2014		November 3, 2013
	Finished goods	$	60	$	53

	Work-in-process	156		154

	Raw materials	85		78

	Total inventory	$	301	$	285

Acquisitions

Acquisitions	6 Months Ended
	4-May-14
Business Combinations [Abstract]	'
Acquisitions and Investment	'
	Acquisitions and Investment

	LSI Corporation
	On May 6, 2014, subsequent to the end of our second fiscal quarter, which ended on May 4, 2014, we completed our previously announced acquisition of all of the issued and outstanding shares of common stock of LSI Corporation, or LSI, a U.S. publicly traded company that designs semiconductors that accelerate storage and networking in data centers, mobile networks and client computing, for an aggregate acquisition consideration of approximately $6.5 billion in cash, or $11.15 in cash per share of LSI common stock. (See Notes 6. "Borrowings" and 15. "Subsequent Events" for further details.)
	CyOptics
	On June 28, 2013, we completed our acquisition of all of the outstanding shares of capital stock of CyOptics, a U.S.-based company that manufactures and sells Indium Phosphide, or InP, optical chip and component technologies for the data communications and telecommunications markets. CyOptics has front-end manufacturing operations in the U.S. and back-end manufacturing operations in Mexico. As a result of the CyOptics acquisition, we acquired approximately 1,100 additional employees, with 745 of these employees located in Mexico.
	The aggregate consideration for the acquisition was approximately $377 million of which $373 million was paid in cash, net of $3 million in cash acquired. We also agreed to pay additional deferred consideration to the previous shareholders of CyOptics in the amount of $4 million one year subsequent to the acquisition date, which was recorded in other current liabilities.
	An additional approximately $27 million is payable to key employees of CyOptics as part of a retention bonus plan. This amount was paid into escrow and will be paid to those employees over a three-year period subsequent to the acquisition date and is being recognized as compensation expense in operating results over the same period. For eligible CyOptics employees whose employment is involuntarily terminated by the Company, their retention bonus payments are accelerated and due in full upon such termination in accordance with the provisions of the plan. During the fiscal quarter and two fiscal quarters ended May 4, 2014, we recorded a compensation expenses of $1 million and $10 million, respectively, due to the departures of certain plan participants.
	We have preliminarily estimated the fair value of the acquired assets and liabilities for CyOptics. We allocated the purchase price to tangible assets, liabilities and identifiable intangible assets acquired based on their estimated fair values. The excess of the purchase price over the aggregate fair values was recorded as goodwill. The fair value assigned to identifiable intangible assets acquired was based on estimates and assumptions made by management at the time of acquisition. As additional information becomes available, such as finalization of negotiations of working capital adjustments and tax related matters, we have revised and may continue to revise our preliminary purchase price allocation.
	Our allocation of the total purchase price for CyOptics and the purchased intangible assets as of May 4, 2014 is as follows (in millions):


		Fair Value
	Trade accounts receivable	$	51

	Inventory	35

	Other current assets	2

	Property, plant and equipment	44

	Goodwill	190

	Intangible assets	141

	Total assets acquired	463

	Accounts payable	(25		)
	Employee compensation and benefits	(5		)
	Other current liabilities	(2		)
	Long-term deferred tax liabilities (included in Other long-term liabilities)	(54		)
	Total liabilities assumed	(86		)
	Purchase price allocation	$	377

	There were no significant contingencies assumed as part of the acquisition. As of May 4, 2014, we have a $12 million indemnification receivable in other long-term assets for tax positions related to CyOptics' value-added tax and income tax payables existing prior to the acquisition.


		Fair Value			Estimated Useful
		(in millions)			Lives (in years)
	Purchased intangible assets
	Purchased technology - base product	$	98		8

	Purchased technology - packaging	3			5

	Customer relationships	32			7

	Other - customer backlog	4			1

	Total identified intangible finite lived assets	137

	In process research and development indefinite lived assets	4

	Total identified intangible assets	$	141

	Purchased Intangible Assets. Developed technology represents base product technology and packaging technology. We valued the base product technology that generates cash flows from sales of the existing products using the income approach, specifically the multi-period excess earnings method which calculates the value based on the risk-adjusted present value of the cash flows specific to the products, allowing for a reasonable return. The useful life of 8 years was determined based on the technology cycle related to the base product technology as well as the life of current legacy products.
	Packaging technology is valued utilizing the relief-from-royalty method, a form of the income approach. The relief-from-royalty method estimates the cost savings that accrue to the owner of an intangible asset that would otherwise be payable as royalties or license fees on revenues earned through the use of the asset. The royalty rate is based on an analysis of empirical, market-derived royalty rate for guideline intangible assets.
	Customer relationships represent the fair value of future projected revenue that will be derived from sales of products to existing customers of CyOptics. Customer relationships were valued using the with-and-without-method, a form of the income approach. In this method, fair value is measured by the lost profits associated with the period of time necessary to reacquire the customers. The method involves a comparison of the cash flows assuming the customer relationships were in place versus as if the customer relationships were to be created "from scratch." There are additional considerations related to the build-in time for certain product lines and the qualification periods included in the valuation model. This method also assumes that all other assets, know-how and technology were easily available in both scenarios.
	The fair value of in-process research and development, or IPR&D, from the CyOptics acquisition was determined using the multi-period excess earnings method, a form of the income approach. Under the income approach, the expected future cash flows from each project under development are estimated and discounted to their net present values at an appropriate risk-adjusted rate of return.
	We believe the amount recorded as developed technology, IPR&D and customer relationships, represent the fair value of and approximate the amount a market participant would pay for these projects as of the acquisition date.
	The purchased intangible assets are being amortized over their estimated useful lives of 1 year to 8 years. (See Note 4. Goodwill and Intangible Assets)
	Unaudited Pro Forma Information. The following table presents certain unaudited pro forma financial information for each of the fiscal years ended November 3, 2013 and October 28, 2012 as if CyOptics had been acquired as of the beginning of the fiscal year prior to the acquisition date. The unaudited estimated pro forma information combines the historical results of CyOptics with our consolidated historical results and includes certain fair value adjustments reflecting the estimated impact of amortization of purchased intangible assets and depreciation of acquired property, plant and equipment for the respective periods. The pro forma data are for informational purposes only and are not necessarily indicative of the consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of our fiscal year 2012 or of the results of future operations of the combined business. Consequently, actual results will differ from the unaudited pro forma information presented below (in millions, except for per share amounts):


	Fiscal Year Ended
	3-Nov-13				28-Oct-12
Pro forma net revenue	$	2,663			$	2,578

Pro forma net income	$	547			$	551

Pro forma net income per share-basic	$	2.21			$	2.25

Pro forma net income per share-diluted	$	2.17			$	2.2

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	6 Months Ended
	4-May-14
Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table] [Line Items]	'
Goodwill and Intangible Assets Disclosure [Text Block]	'
	Goodwill and Intangible Assets
	Goodwill
	There was no material change in the goodwill balance for the period ended May 4, 2014.
	Intangible Assets
	Purchased intangibles consist of the following (in millions):


		Gross Carrying		Accumulated			Net Book Value
		Amount		Amortization
	As of May 4, 2014:
	Purchased technology	$	843	$	(498	)	$	345

	Customer and distributor relationships	289		(199		)	90

	Other	8		(6		)	2

	Intangible assets subject to amortization	1,140		(703		)	437

	In-process research and development	4		—			4

	Total	$	1,144	$	(703	)	$	441


	As of November 3, 2013:
	Purchased technology	$	843	$	(462	)	$	381

	Customer and distributor relationships	289		(186		)	103

	Other	8		(4		)	4

	Intangible assets subject to amortization	1,140		(652		)	488

	In-process research and development	4		—			4

	Total	$	1,144	$	(652	)	$	492

	The following table presents the amortization expense of purchased intangible assets (in millions):


		Fiscal Quarter Ended					Two Fiscal Quarters Ended
		May 4,		May 5,			May 4,		May 5,
		2014		2013			2014		2013
	Cost of products sold	$	18	$	14		$	36	$	28

	Operating expenses	8		6			15		11

	Total amortization expense	$	26	$	20		$	51	$	39

	Based on the amount of intangible assets subject to amortization at May 4, 2014, the expected amortization expense for each of the next five fiscal years and thereafter is as follows (in millions):


	Fiscal Year	Amount
	2014 (remainder)	$	49

	2015	95

	2016	78

	2017	68

	2018	33

	2019	29

Thereafter	85

	$	437

The weighted-average amortization periods remaining by intangible asset category at May 4, 2014 were as follows (in years):


Amortizable intangible assets:
Purchased technology	7
Customer and distributor relationships	6
Other	13

Retirement_Plans_and_PostRetir

Retirement Plans and Post-Retirement Benefits	6 Months Ended
Retirement Plans and Post-Retirement Benefits	4-May-14
Compensation and Retirement Disclosure [Abstract]	'
Retirement Plans and Post-Retirement Benefits	'
	Retirement Plans and Post-Retirement Benefits
	An amendment was made to our U.S. post-retirement medical benefit plan with an effective date of January 1, 2014. This plan was transferred to us from Agilent Technologies, Inc., or Agilent, as part of the Semiconductor Products Group, or SPG, acquisition on December 1, 2005. The amendment affected active, eligible employees and had no impact on existing retirees. As a result of the amendment, employees who were previously eligible for the medical benefit spending account of $40,000 upon retirement received a cash settlement based on age and years of service and have ceased to be eligible for post-retirement medical benefits under the program. During the first two quarters of fiscal year 2014, we paid an aggregate of $6 million in cash into these employees' 401(k) accounts. Employees who were previously eligible for the medical benefit spending account of $55,000 upon retirement have had the period during which they, as retirees, may use the spending account to pay premiums paid for medical coverage extended from age 65 to 75. Employees who were previously eligible for the traditional retiree medical plan upon retirement have ceased to be eligible to participate in such a plan and will, instead, only be eligible for the extended $55,000 retiree medical account program described above. As a result of the above plan amendment, a curtailment gain of $1 million and a settlement gain of $2 million were recorded in the unaudited condensed consolidated financial statements for the fiscal quarter ended February 2, 2014. As of May 4, 2014, the U.S. post-retirement medical benefit plan's remaining liability balance was $14 million, which is primarily included in other long-term liabilities in our unaudited condensed consolidated balance sheet.
	During the fiscal quarter ended May 4, 2014, a plan amendment, effective March 1, 2014 was made to the non-U.S. defined benefit plan for Korea. This amendment resulted in a cash settlement of $7 million being paid into the new defined contribution plan, of which $2 million was paid from the plan assets during the fiscal quarter ended May 4, 2014. The plan amendment eliminated the plan's $5 million benefit obligation. The settlement impact recorded in results from operations was immaterial.

Borrowings

Borrowings	6 Months Ended
Borrowings	4-May-14
Debt Disclosure [Abstract]	'
Borrowings	'
	Borrowings
	Senior Credit Facilities
	As of May 4, 2014, we had an unsecured, revolving credit facility, or the 2013 revolving credit facility, in the amount of $575 million, which included borrowing capacity available for letters of credit. As of May 4, 2014, we had no borrowings outstanding under this revolving credit facility, and we were in compliance with the covenants under the related credit agreement, or the 2013 credit agreement. The 2013 credit agreement was terminated in connection, and simultaneously with the completion of our acquisition of LSI, on May 6, 2014. Subsequent to our second fiscal quarter, which ended on May 4, 2014, on May 6, 2014, in connection with the completion of our acquisition of LSI, we entered into a senior collateralized credit agreement, or the 2014 credit agreement, with a syndicate of banks, which provides for a term loan facility in the aggregate principal amount of $4.6 billion (all of which was drawn and used to fund our acquisition of LSI) and a revolving credit facility that permits certain of our subsidiaries to borrow loans from time to time in an aggregate principal amount of up to $500 million for general corporate purposes. See Note 15. "Subsequent Events" for additional details.
	Convertible Senior Notes
	On May 6, 2014, also in connection with the completion of our acquisition of LSI, we completed our previously announced private placement of $1 billion in aggregate principal amount of 2.0% Convertible Senior Notes due 2021, or the Notes, to investment funds affiliated with Silver Lake Partners, all of the proceeds of which were used to fund the LSI acquisition. See Note 11. "Related Party Transactions" and Note 15. "Subsequent Events" for additional details.
	Debt Issuance Costs
	Unamortized debt issuance costs associated with our 2013 revolving credit facility were $2 million at May 4, 2014. These unamortized debt issuance costs are included in other current assets and other long-term assets on the unaudited condensed consolidated balance sheets. Amortized debt issuance costs associated with our 2013 revolving credit facility are classified as interest expense in the unaudited condensed consolidated statements of operations. Prepaid debt issuance costs associated with our 2014 credit agreement were $5 million at May 4, 2014.

Fair_Value

Fair Value	6 Months Ended
	4-May-14
Fair Value Disclosures [Abstract]	'
Fair Value	'
	Fair Value
	Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three level hierarchy is applied to prioritize the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).
	The three levels of the fair value hierarchy under the guidance for fair value measurements are described below:
	Level 1—Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Our Level 1 assets include bank acceptances, and investment funds (i.e., deferred compensation plan assets). We measure investment funds at quoted market prices as they are traded in an active market with sufficient volume and frequency of transactions.
	Level 2—Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability.
	Level 3—Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. Level 3 assets and liabilities include cost method investments, goodwill, amortizable intangible assets, and property, plant and equipment, which are measured at fair value using a discounted cash flow approach when they are impaired. Quantitative information for Level 3 assets and liabilities reviewed at each reporting period includes indicators of significant deterioration in the earnings performance, credit rating, asset quality, business prospects of the investee, and financial indicators of the investee's ability to continue as a going concern.
	We did not have any Level 3 asset or liability activities during the fiscal quarter and the two fiscal quarters ended May 4, 2014.
	Assets and Liabilities Measured at Fair Value on a Recurring Basis
	The table below sets forth by level our financial assets and liabilities that were accounted for at fair value as of May 4, 2014. The table does not include cash on hand and also does not include assets that are measured at historical cost or any basis other than fair value (in millions).


		As of May 4, 2014
		Portion of Carrying		Fair Value		Fair Value Measurement Using Significant Other Inputs (Level 2)		Fair Value Measurement
		Value Measured at Fair		Measurement Using				Using Unobservable Inputs
		Value		Quoted Prices				(Level 3)
				In Active Market
				For Identical
				Assets
				(Level 1)
	Assets:
	Investment funds — deferred compensation plan assets (1)	$	12	$	12	$	—	$	—

	Bank acceptances (1)	1		1		—		—

	Total assets measured at fair value	$	13	$	13	$	—	$	—

	Liabilities:
	Deferred compensation plan liabilities (2)	$	12	$	—	$	12	$	—

	_________________________________


	-1	Included in other current assets in our unaudited condensed consolidated balance sheet

	-2	Included in other current liabilities in our unaudited condensed consolidated balance sheet
	During the fiscal quarter and two fiscal quarters ended May 4, 2014, there were no material transfers between Level 1, Level 2 or Level 3 fair value instruments.
	Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis
	There were no non-financial assets or liabilities measured at fair value as of May 4, 2014.
	Fair Value of Other Financial Instruments
	The fair values of cash equivalents, trade accounts receivable, accounts payable, other current assets, employee compensation and benefits and other current liabilities, to the extent the underlying liability will be settled in cash, approximate carrying values because of the short-term nature of these instruments.

Shareholders_Equity

Shareholders' Equity	6 Months Ended
	4-May-14
Equity [Abstract]	'
Shareholders' Equity	'
	Shareholders’ Equity
	Share Repurchase Program
	Under the 2013 share repurchase program, the Company repurchased 0.3 million shares for an aggregate purchase price of $12 million in cash at a weighted-average purchase price per share of $43.50 during the two fiscal quarters ended May 4, 2014. There were no shares repurchased during the fiscal quarter ended May 4, 2014. The 2013 share repurchase program expired on April 8, 2014. At the Company's 2014 annual general meeting of shareholders on April 9, 2014, shareholders approved the Company's 2014 share purchase mandate pursuant to which the Company is authorized, upon the approval of the Company's board of directors, or the Board, to repurchase up to approximately 25 million of its ordinary shares in open market transactions or pursuant to equal access schemes, up to the date on which the Company's 2015 annual general meeting of shareholders is held or required by law to be held, referred to as the 2014 share purchase mandate. As of the date of this Quarterly Report on Form 10-Q, the Board had not approved any repurchases of the Company's ordinary shares pursuant to the 2014 share purchase mandate.
	Dividends
	We paid a cash dividend of $0.27 and $0.19 per ordinary share of the Company, or $68 million and $47 million in total, during the fiscal quarters ended May 4, 2014 and May 5, 2013, respectively. We paid aggregate cash dividends of $130 million and $89 million during the two fiscal quarters ended May 4, 2014 and May 5, 2013, respectively.
	Share-Based Compensation Expense
	The following table summarizes share-based compensation expense related to share-based awards granted to employees, directors, and non-employees for the fiscal quarter and two fiscal quarters ended May 4, 2014 and May 5, 2013 (in millions):


		Fiscal Quarter Ended								Two Fiscal Quarters Ended
		May 4,				May 5,				May 4,				May 5,
		2014				2013				2014				2013
	Cost of products sold	$	3			$	2			$	6			$	4

	Research and development	10				7				18				14

	Selling, general and administrative	17				8				30				17

	Total share-based compensation expense	$	30			$	17			$	54			$	35

	The fair values of our time-based options and ESPP rights were estimated using the Black-Scholes option pricing model. Certain stock options granted in the fiscal quarter and two fiscal quarters ended May 4, 2014 and May 5, 2013, respectively, included both service and market conditions. The fair value of those market-based stock options was estimated using Monte Carlo simulation techniques.
	The weighted-average assumptions utilized for our time-based options, ESPP rights and share price performance options, also referred to as market-based options granted during the fiscal quarter and two fiscal quarters ended May 4, 2014 and May 5, 2013 were as follows:


		Time-Based Options
		Fiscal Quarter Ended						Two Fiscal Quarters Ended
		May 4,			May 5,			May 4,			May 5,
		2014			2013			2014			2013
	Risk-free interest rate	1.3	%		0.9	%		1.3	%		0.9	%
	Dividend yield	1.7	%		1.9	%		1.8	%		1.9	%
	Volatility	35	%		48	%		35	%		49	%
	Expected term (in years)	4.3			5			4.2			5



		ESPP Rights
		Fiscal Quarter Ended						Two Fiscal Quarters Ended
		May 4,			May 5,			May 4,			May 5,
		2014			2013			2014			2013
	Risk-free interest rate	0.1	%		0.1	%		0.1	%		0.1	%
	Dividend yield	1.7	%		2.1	%		2	%		2	%
	Volatility	31	%		46	%		34	%		45	%
	Expected term (in years)	0.5			0.5			0.5			0.5



		Market-Based Options
		Fiscal Quarter Ended						Two Fiscal Quarters Ended
		May 4,			May 5,			May 4,			May 5,
		2014			2013			2014			2013
	Risk-free interest rate	2.3	%		1.4	%		2.3	%		1.4	%
	Dividend yield	1.7	%		1.9	%		1.8	%		1.9	%
	Volatility	45	%		50	%		45	%		50	%
	Expected term (in years)	7			7			7			7

	The dividend yields for the fiscal quarters and the two fiscal quarters ended May 4, 2014 and May 5, 2013 are based on the dividend yield as of the respective award grant dates. For the two fiscal quarters ended May 4, 2014, expected volatility for time-based and market-based options is based on our own historical share price volatility and or combining historical volatility of guideline publicly traded companies and our own historical share price volatility over the period commensurate with the expected life of the awards and the implied volatility from our own traded shares with a term of 180 days measured at a specific date. Prior to fiscal year 2014, expected volatility was based on the combination of historical volatility of guideline publicly-traded companies and our own historical share price volatility over the period commensurate with the expected life of the awards and the implied volatility from traded options in guideline publicly-traded companies and our own shares with a term of 720 days or greater measured over the last three months.
	The risk-free interest rate is derived from the average U.S. Treasury Strips rate during the period, which approximates the rate in effect at the time of grant.
	For the fiscal quarter and two fiscal quarters ended May 4, 2014, the expected term for time-based options was based on a weighted-average combining the average life of options that have already been exercised or cancelled with the expected life of all unexercised options. The expected life for unexercised options is calculated assuming that the options will be exercised at the midpoint of the vesting date (if unvested) or the valuation date (if vested) and the full contractual term. Our computations of expected term for time-based options prior to fiscal year 2014 were based on data, such as the data of peer companies and company-specific attributes, that we believe could affect employees’ exercise behavior.
	The expected life of market-based stock options valued using Monte Carlo simulation techniques is based upon the vesting dates forecasted by the simulation and then assuming that options which vest, and for which the market condition has been satisfied, are exercised at the midpoint between the forecasted vesting date and their expiration.
	Based on the above assumptions, the weighted-average fair values of the time-based options granted under the Company's equity incentive award plan for the fiscal quarters ended May 4, 2014 and May 5, 2013 were $16.04 and $12.53, respectively and $15.56 and $12.65 for the two fiscal quarters ended May 4, 2014 and May 5, 2013, respectively.
	The weighted-average fair values of the market-based options granted under the Company's equity incentive award plan for the fiscal quarter ended May 4, 2014 and May 5, 2013 were $22.33 and $13.34, respectively and $20.79 and $13.34 for the two fiscal quarters ended May 4, 2014 and May 5, 2013, respectively.
	The weighted-average fair values of the rights to purchase shares in the ESPP for the fiscal quarters ended May 4, 2014 and May 5, 2013 were $14.61 and $11.73, respectively and $13.44 and $11.63 for the two fiscal quarters ended May 4, 2014 and May 5, 2013, respectively.
	The weighted-average fair values of RSUs granted in the fiscal quarters ended May 4, 2014 and May 5, 2013 were $62.06 and $35.46, respectively and $59.03 and $35.34 for the two fiscal quarters ended May 4, 2014 and May 5, 2013, respectively.
The total compensation expense of time and market-based options granted but not yet vested as of May 4, 2014 was $230 million, which is expected to be recognized over the remaining weighted-average service period of 3 years.
The total grant date fair values of time and market-based options vested during the fiscal quarters ended May 4, 2014 and May 5, 2013 were $32 million and $19 million, respectively. The total grant-date fair values of options that vested during the two fiscal quarters ended May 4, 2014 and May 5, 2013 were $42 million and $27 million, respectively.
Total unrecognized compensation cost related to the ESPP rights as of May 4, 2014 was $1 million and is expected to be recognized over the remaining portion of the current offering period under the ESPP, which ends on September 14, 2014.
Total compensation cost related to unvested RSUs as of May 4, 2014 was $62 million, which is expected to be recognized over the remaining weighted-average service period of 3 years. The total grant-date fair values of RSUs that vested during the fiscal quarters ended May 4, 2014 and May 5, 2013 were $12 million and $1 million, respectively. The total grant-date fair values of RSUs that vested during the two fiscal quarters ended May 4, 2014 and May 5, 2013 were $13 million and $1 million, respectively.
Equity Incentive Award Plans
A summary of option award activity related to our equity incentive plans is as follows (in millions, except years and per share amounts):


				Option Awards Outstanding
	Shares			Number			Weighted-				Weighted-		Aggregate
	Available			Outstanding			Average				Average		Intrinsic
	for Grant						Exercise Price				Remaining		Value
							Per Share				Contractual
											Life (in years)
Balance as of November 3, 2013	10			22			$	29.81

Annual increase in shares available for issuance, per equity incentive plan terms	6

Granted	(7	)		7			59.56

Exercised	—			(2	)		24.28

Cancelled	—			—			36.67

Balance as of May 4, 2014	9			27			37.82				5.65		$	705

Fully vested as of May 4, 2014				8			23.7				4.82		339

Fully vested and expected to vest as of
4-May-14				25			37.14				5.61		682

As of November 3, 2013, there were 10 million shares available for grant under the 2009 Equity Incentive Plan. Per the terms of the 2009 Equity Incentive Plan, an annual increase of 6 million shares was approved for issuance on the first day of fiscal year 2014. As of the quarter ended May 4, 2014, there were 9 million shares that remained available for grant.
The total intrinsic values of options exercised during the fiscal quarters ended May 4, 2014 and May 5, 2013 were $46 million and $17 million, respectively. The total intrinsic values of options exercised during the two fiscal quarters ended May 4, 2014 and May 5, 2013 were $69 million and $42 million, respectively.
A summary of RSU activity related to our equity incentive plans is as follows (in millions, except years and per share amounts):


		RSU Awards Outstanding
		Number			Weighted-				Weighted-
		Outstanding			Average				Average
					Grant Date				Remaining
					Fair Market Value				Contractual
									Life (in years)
Balance as of November 3, 2013		2			$	34.38

Granted		1			59.02

Vested		(1	)		33.89

Forfeited		—			39.04

Balance as of May 4, 2014		2			43.05				3.16

The following table summarizes the ranges of outstanding and exercisable option awards as of May 4, 2014 (in millions, except years and per share amounts):


		Option Awards Outstanding									Option Awards Exercisable
Exercise Prices		Number Outstanding			Weighted-		Weighted-Average				Number Exercisable			Weighted-Average
					Average		Exercise Price Per Share							Exercise Price Per Share
					Remaining
					Contractual
					Life (in years)
$0.00-$10.00		1			4.06		$	8.47			1			$	8.49

$10.01-$20.00		2			4.55		13.31				2			13.33

$20.01-$30.00		2			6.16		21				1			20.86

$30.01-$40.00		15			5.34		35.48				4			34.19

$40.01-$50.00		1			6.47		45.56				—			—

$50.01-$60.00		1			6.69		53.57				—			—

$60.01-$63.18		5			6.84		62.01				—			—

Total		27			5.65		37.82				8			23.7

Employee Share Purchase Plan
0.1 million shares were issued under the ESPP during each of the fiscal quarter and two fiscal quarters ended May 4, 2014 and May 5, 2013. At May 4, 2014, 9.2 million shares remained available for issuance under the ESPP.

Income_Taxes

Income Taxes	6 Months Ended
Income Taxes	4-May-14
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Income Taxes
	For the fiscal quarter and two fiscal quarters ended May 4, 2014, we recorded an income tax provision of $1 million and $6 million, respectively, compared to $5 million and $6 million for the fiscal quarter and two fiscal quarters ended May 5, 2013, respectively. The tax expense for the fiscal quarter and two fiscal quarters ended May 4, 2014 included a benefit of $10 million and $14 million, respectively, from the recognition of previously unrecognized tax benefits as a result of lapses in statutes of limitations for various audit periods. The tax expense for the two fiscal quarters ended May 5, 2013 included a benefit of $3 million from the enactment of the American Taxpayer relief Act of 2012, which was signed into law on January 2, 2013, retroactively extending the U.S. Federal Research and Development tax credit from January 1, 2012 to December 31, 2013. The remaining changes in tax provisions for all periods presented were mainly due to changes in the jurisdictional mix of income and expense.
	Pursuant to Accounting Standards Codification (“ASC”) 740-10-25-3(e) (Income Taxes) and ASC 810-10-45-8 (Consolidation), during the fiscal quarter ended February 2, 2014, we recorded a deferred charge for the deferral of income tax expense on certain intercompany asset transactions that occurred in the quarter. The deferred charge of approximately $32 million, with $4 million included in other current assets and $28 million included in other long-term assets on our unaudited condensed consolidated balance sheets. The deferred charge will be amortized on a straight-line basis and will be included as a component of income tax expense over the life of the underlying assets, which has been estimated to be seven years.
	Unrecognized Tax Benefits
	As of November 3, 2013, the amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate was approximately $35 million, including accrued interest and penalties.
	We are subject to Singapore income tax examinations for the years ended November 1, 2009 and later, and in major jurisdictions outside Singapore for the years ended October 31, 2008 and later. However, we are not under Singapore income tax examination at this time. We believe it is possible that we may recognize up to $3 million of our existing unrecognized tax benefits within the next 12 months as a result of lapses of statute of limitations for certain audit periods.

Segment_Information

Segment Information	6 Months Ended
Segment Information	4-May-14
Segment Reporting [Abstract]	'
Segment Information	'
	Segment Information
	ASC 280 “Segment Reporting,” or ASC 280, establishes standards for the way public business enterprises report information about operating segments in annual consolidated financial statements and requires that those enterprises report selected information about operating segments in interim financial reports. ASC 280 also establishes standards for related disclosures about products and services, geographic areas and major customers. We completed the CyOptics acquisition in the third quarter of fiscal year 2013 and have fully integrated CyOptics into Avago's organization structure and business model. Therefore, we have concluded that we continue to have one reportable segment based on the following factors: sales of semiconductors represents our only material source of revenue; substantially all products offered incorporate analog functionality and are manufactured under similar manufacturing processes; we use an integrated approach in developing our products in that discrete technologies developed are frequently integrated across many of our products; and we use a common order fulfillment process and similar distribution approach for our products. Broad distributor networks are typically used to distribute our products, with large accounts being serviced by a direct sales force. The Chief Executive Officer has been identified as the Chief Operating Decision Maker, as defined by ASC 280.

Related_Party_Transactions

Related Party Transactions	6 Months Ended
	4-May-14
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	Related Party Transactions
	During the fiscal quarter and the two fiscal quarters ended May 4, 2014 and May 5, 2013, in the ordinary course of business, the Company purchased from, or sold to, several entities where one of the Company's directors also serves or served as a director or executive officer of that entity, including eSilicon Corporation (ceased to be a related party after the quarter ended May 5, 2013), KLA-Tencor Corporation, Kulicke & Soffa Industries, Inc. and Wistron Corporation (ceased to be a related party after the quarter ended August 4, 2013). Management believes that such transactions are at arm's length and on similar terms as would have been obtained from unaffiliated third parties.
	The following tables provide information regarding the aggregate amounts involved in the transactions with these parties for the indicated periods (for the portion of such period that they were considered related) (in millions):


		Fiscal Quarter Ended						Two Fiscal Quarters Ended
		May 4,			May 5,			May 4,			May 5,
		2014			2013			2014			2013
	Total net revenue (1) (2)	$	—		$	10		$	—		$	16

	Total costs and expenses (2)	—		*	1			—		*	2



		May 4,			November 3,
		2014			2013
	Total receivables	$	—		$	—	*

	Total payables	—		*	—		*

	_________________________________
	* Represent amounts less than $0.5 million.
	(1) Amounts include net revenue for related party transactions with Wistron Corporation through the fiscal quarter ended May 5, 2013. Wistron Corporation ceased to be a related party after the fiscal quarter ended August 4, 2013.
	(2) Amounts include net revenue, cost and expenses for related party transactions with eSilicon Corporation through the fiscal quarter ended May 5, 2013. eSilicon Corporation ceased to be a related party after the fiscal quarter May 5, 2013.
	Convertible Senior Notes
	On December 15, 2013, in connection with our acquisition of LSI, the Company entered into a Note Purchase Agreement with Silver Lake Partners IV, L.P, or SLP IV as the Purchaser and Deutsche Bank, A.G., Singapore Branch, as Lead Manager, referred to as the Note Purchase Agreement, in connection with the private placement of $1 billion aggregate principal amount of the Company's 2.0% Convertible Senior Notes due 2021. Silver Lake Partners IV an investment fund affiliated with Silver Lake Partners, of which Kenneth Hao, one of our directors, is a Managing Director. Mr. Hao disclaims all beneficial interest in the Notes, except to the extent of his pecuniary interest therein. We completed the private placement of the Notes on May 6, 2014, in connection with the completion of the acquisition of LSI. See Note 6. "Borrowings" for additional details.

Commitments_and_Contingencies

Commitments and Contingencies	6 Months Ended
	4-May-14
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Commitments and Contingencies
	Commitments
	The following table sets forth changes in our commitments as of May 4, 2014 for the fiscal periods noted (in millions):


		Total		2014 (remainder)		2015		2016		2017		2018		2019		Thereafter
	Purchase Commitments	$	216	$	216	$	—	$	—	$	—	$	—	$	—	$	—

	Other Contractual Commitments	$	50	$	11	$	16	$	13	$	6	$	4	$	—	$	—

	Purchase Commitments. We have unconditional purchase obligations which include agreements to purchase goods or services that are enforceable and legally binding on us and that specify all significant terms, including fixed or minimum quantities to be purchased, fixed, minimum or variable price provisions and the approximate timing of the transaction. Purchase obligations exclude agreements that are cancelable without penalty.
	We also make purchases from a variety of vendors in connection with the expansion of our Fort Collins internal fabrication facility. These purchases are typically conducted on a purchase order basis and the purchase commitments amount shown in the table above includes $67 million in cancelable and non-cancelable outstanding purchase obligations under such purchase orders as of May 4, 2014.
	Other Contractual Commitments. Represents amounts payable pursuant to agreements related to outsourced IT, human resources, financial infrastructure outsourcing services and other services agreements.
	There were no other substantial changes to our contractual commitments during the first two quarters of fiscal year 2014 from those disclosed in our Annual Report on Form 10-K for fiscal year 2013.
	Contingencies
	From time to time, we are involved in litigation that we believe is of the type common to companies engaged in our line of business, including commercial disputes, employment issues and disputes involving claims by third parties that our activities infringe their patent, copyright, trademark or other intellectual property rights. Legal proceedings are often complex, may require the expenditure of significant funds and other resources, and the outcome of litigation is inherently uncertain, with material adverse outcomes possible. Intellectual property claims generally involve the demand by a third-party that we cease the manufacture, use or sale of the allegedly infringing products, processes or technologies and/or pay substantial damages or royalties for past, present and future use of the allegedly infringing intellectual property. Claims that our products or processes infringe or misappropriate any third-party intellectual property rights (including claims arising through our contractual indemnification of our customers) often involve highly complex, technical issues, the outcome of which is inherently uncertain. Moreover, from time to time we pursue litigation to assert our intellectual property rights. Regardless of the merit or resolution of any such litigation, complex intellectual property litigation is generally costly and diverts the efforts and attention of our management and technical personnel.
	Lawsuits Relating to the Acquisition of LSI
	Fifteen purported class action complaints have been filed by alleged stockholders of LSI against us. Eight of those lawsuits were filed in the Delaware Court of Chancery, and the other seven lawsuits were filed in the Superior Court of the State of California, County of Santa Clara on behalf of the same putative class as the Delaware actions (the "California Actions"). On January 17, 2014, the Delaware Court of Chancery entered an order consolidating the Delaware actions into a single action (the "Delaware Action"). These actions generally allege that we aided and abetted breaches of fiduciary duty by the members of LSI's board of directors in connection with the merger because the merger was not in the best interest of LSI, the merger consideration is unfair and certain other terms of the merger agreement are unfair. Among other remedies, the lawsuits seek to enjoin the merger, or in the event that an injunction is not entered and the merger closes, to rescind the merger or obtain unspecified money damages, costs and attorneys' fees.
	On March 7, 2014, the parties to the Delaware Action reached an agreement in principle to settle the Delaware Action on a class wide basis, and negotiated a stipulation of settlement that was presented to the Delaware Court of Chancery on March 10, 2014. On March 12, 2014, the parties to the California Actions entered into a stipulation staying the California Actions pending resolution of the Delaware Action. On May 16, 2014, the plaintiffs in the Delaware Action filed a motion for final approval of the proposed settlement and award of attorneys’ fees and expenses with the Delaware Court of Chancery. We and our Board believe these claims are entirely without merit and, in the event the settlement is not approved, we intend to vigorously defend these actions.
	Other Matters
	In addition to the matters discussed above, we are currently engaged in a number of legal actions in the ordinary course of our business.
	While there can be no assurance, we do not believe that we are involved in any pending legal proceedings that would be reasonably possible to have a material adverse effect on our financial condition, results of operations or cash flows. During the periods presented we have not recorded any accrual for loss contingencies associated with any legal proceedings nor determined that an unfavorable outcome is probable or reasonably possible. As a result, no amounts have been accrued or disclosed in the accompanying unaudited condensed consolidated financial statements with respect to these legal proceedings.
	Warranty
	There were no material changes to our warranty accrual during the fiscal quarter and two fiscal quarters ended May 4, 2014.
	Indemnifications to Hewlett-Packard and Agilent
	Agilent, has given multiple indemnities to Hewlett-Packard Company in connection with its activities prior to its spin-off from Hewlett-Packard Company in June 1999 for the businesses that constituted Agilent prior to the spin-off. We are the successor to the SPG, of Agilent, which we acquired on December 1, 2005, which we refer to as the SPG Acquisition. As the successor to the SPG business of Agilent, we have acquired responsibility for indemnifications related to assigned intellectual property agreements. Additionally, when we completed the acquisition from Agilent in December 2005, we provided indemnities to Agilent with regard to Agilent’s conduct of the SPG business prior to the SPG Acquisition. In our opinion, the fair value of these indemnifications is not material and no amount has been accrued in the accompanying unaudited condensed consolidated financial statements with respect to these indemnification obligations.
	Other Indemnifications
	As is customary in our industry and as provided for in local law in the United States and other jurisdictions, many of our standard contracts provide remedies to our customers and others with whom we enter into contracts, such as defense, settlement, or payment of judgment for intellectual property claims related to the use of our products. From time to time, we indemnify customers, as well as our suppliers, contractors, lessors, lessees, companies that purchase our businesses or assets and others with whom we enter into contracts, against combinations of loss, expense, or liability arising from various triggering events related to the sale and the use of our products, the use of their goods and services, the use of facilities and state of our owned facilities, the state of the assets and businesses that we sell and other matters covered by such contracts, usually up to a specified maximum amount. In addition, from time to time we also provide protection to these parties against claims related to undiscovered liabilities, additional product liability or environmental obligations. In our experience, claims made under such indemnifications are rare and the associated estimated fair value of the liability is not material.

Restructuring_charges_Notes

Restructuring charges (Notes)	6 Months Ended
	4-May-14
Restructuring and Related Activities [Abstract]	'
Restructuring and Related Activities Disclosure [Text Block]	'
	Restructuring Charges
	LSI Acquisition-Related Restructuring Plan
	In April 2014, in order to achieve annual cost savings from the LSI acquisition, we identified approximately 120 employees in Avago's pre-acquisition workforce whose employment will be terminated. We recorded approximately $6 million of employee termination costs related to this cost reduction plan in operating expenses during the fiscal quarter and two fiscal quarters ended May 4, 2014 and expect to record the remaining $8 million of employee termination costs over the remaining retention periods that these employees are expected to provide employment services until their respective exits in the future fiscal quarters. See Note 15. "Subsequent Events" for additional details.
	Fabrication Facility Closure in Italy
	In January 2014, we committed to a restructuring plan to close a fabrication facility as a result of the integration of the CyOptics business. The plan is expected to be substantially completed in the third quarter of fiscal year 2014. We recorded $8 million and $5 million in operating expenses and costs of products sold, respectively, during the two fiscal quarters ended May 4, 2014, related to employment termination costs. As we previously established a pattern for a restructuring plan in the same location, for which similar termination packages were offered, we are therefore required to record the employment termination cost for the current restructuring plan in the period in which the plan was approved by our management in accordance with relevant accounting guidance. As of May 4, 2014, none of this accrued charge has been paid and the remaining balance will be paid during fiscal year 2014 as the employees exit the Company. In addition, we also recorded an impairment of fixed assets of $1 million in operating expenses during the fiscal quarter and two fiscal quarters ended May 4, 2014. Other remaining costs, including impairment of fixed assets and lease termination expenses of approximately $4 million, will be recorded in future quarters pursuant to the relevant accounting guidance.
	Others
	We also incurred restructuring charges of $5 million in operating expenses primarily as a result of rationalizing research and development programs and continued alignment of our global manufacturing operations during the first two quarters of fiscal year 2014.
	The following table sets forth significant activities within and components of the restructuring charges during the two fiscal quarters of fiscal 2014 (in millions):


		Employee Termination Cost		Asset Abandonment Costs		Other		Total
	Balance as of November 3, 2013	$	—	$	—	$	—	$	—

	Cost of product sold	5		—		—		5

	Operating expenses	17		2		1		20

	Less: Non-cash portion	—		2		—		2

	Less: Cash payments	4		—		1		5

	Accrued balance as of May 4, 2014 - included in Other current liabilities	$	18	$	—	$	—	$	18

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Notes)	6 Months Ended
	4-May-14
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Accumulated other comprehensive income (loss) [Text Block]	'
	Accumulated Other Comprehensive Income (Loss)
	The change in accumulated other comprehensive income (loss) by component and related tax effects for the period below is as follows (in millions):


		Prior Service Credits (Cost)			Actuarial Gains (Losses)			Total
	Balance as of November 3, 2013	$	(1	)	$	(5	)	$	(6	)
	Other comprehensive income (loss) before reclassifications	1			—			1

	Amounts reclassified out of accumulated other comprehensive loss	(1		)	(2		)	(3		)
	Tax effects	—			1			1

	Other comprehensive loss	—			(1		)	(1		)

	Balance as of May 4, 2014	$	(1	)	$	(6	)	$	(7	)
	The amounts reclassified out of accumulated other comprehensive income (loss) into the unaudited condensed consolidated statements of operations, with presentation location, during each period were as follows (in millions):


			Fiscal Quarter Ended						Fiscal Two Quarters Ended
	Comprehensive Income Components		May 4,			May 5,			May 4,		May 5,		Classified to:
			2014			2013			2014		2013
	Post-retirement benefit amendment, curtailment and settlement gain, net		$	—		$	—		$	1	$	—	Cost of products sold

	Post-retirement benefit amendment, curtailment and settlement gain, net		—			—			1		—		Research and development

	Post-retirement benefit amendment, curtailment and settlement gain, net		—			—			1		—		Selling, general and administrative

	Total amounts reclassified out of accumulated other comprehensive income (loss)		$	—		$	—		$	3	$	—

Subsequent_Events

Subsequent Events	6 Months Ended
Subsequent Events	4-May-14
Subsequent Events [Abstract]	'
Subsequent Events	'
	Subsequent Events

	LSI Acquisition
	On May 6, 2014, we completed our acquisition of all of the issued and outstanding shares of common stock of LSI, pursuant to the terms of the Agreement and Plan of Merger, dated as of December 15, 2013, or the Merger Agreement, by and among the Company, LSI and the other parties named therein. Pursuant to the Merger Agreement, the acquisition was structured as a merger of an indirect wholly-owned subsidiary of the Company with and into LSI, or the Merger, with LSI surviving the Merger and continuing as an indirect wholly-owned subsidiary of the Company. The aggregate consideration for the acquisition was approximately $6.5 billion in cash, or $11.15 in cash per share of LSI common stock. We funded the transaction with the net proceeds from the issuance of $1 billion of our Convertible Senior Notes, $4.6 billion in term loans under our 2014 Credit Agreement, each discussed in more detail below, as well as $1 billion in cash on hand of the combined companies.
	We are currently evaluating the purchase price allocation following the consummation of the LSI acquisition. It is not practicable to disclose the preliminary purchase price allocation or unaudited pro-forma combined financial information for this transaction, given the short period of time between the acquisition date and the issuance of these unaudited condensed consolidated financial statements.
	Convertible Senior Notes
	In connection with the completion of the acquisition of LSI on May 6, 2014, the Company completed its previously announced private placement of $1 billion in aggregate principal amount of 2.0% Convertible Senior Notes due 2021 or Notes, to investment funds affiliated with Silver Lake Partners, together referred to as the Purchasers, pursuant to the terms of the Note Purchase Agreement among the Company, SLP IV (whose rights and obligations under the Note Purchase Agreement were thereafter assigned to and assumed by the Purchasers) and Deutsche Bank AG, Singapore Branch, as lead manager.
	The Notes were issued pursuant to an Indenture, dated May 6, 2014, or the Indenture, between the Company and U.S. Bank National Association, as trustee. The Indenture includes customary terms and covenants, including certain events of default after which the Notes may be due and payable immediately. The Notes are the Company’s uncollateralized senior obligations. The Notes will mature on August 15, 2021, unless repurchased, redeemed or converted in accordance with their terms prior to such date. The Notes will pay interest semi-annually at a rate of 2.0% per year, payable in arrears on May 1 and November 1 of each year, beginning on November 1, 2014, and on the maturity date. Subject to any limitations set forth in the Indenture, the Notes will be convertible at any time until the close of business on the scheduled trading day immediately preceding the maturity date. Upon conversion, the Notes may be settled in the Company's ordinary shares, cash or a combination of cash and ordinary shares, at the Company’s option. The Notes will be convertible at an initial conversion rate of 20.8160 ordinary shares per $1,000 principal amount of the Notes, which is equivalent to an initial conversion price of approximately $48.04 per ordinary share, and is subject to adjustment under the terms of the Notes (including adjustments for quarterly cash dividends paid on the Company's ordinary shares to the extent they exceed $0.27 per share). Holders of the Notes will have the right to require the Company to repurchase all or some of their Notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the Indenture). In addition, upon the occurrence of a make-whole fundamental change (as defined in the Indenture), Avago may be required to increase the conversion rate for the Notes converted in connection with such a make-whole fundamental change. Prior to May 6, 2019, the Company may not redeem the Notes. Beginning May 6, 2019, the Company may, at its option, redeem the Notes, in whole or in part if the closing sale price (as defined in the Indenture) of the ordinary shares for 20 or more trading days (as defined in the indenture) in the period of 30 consecutive trading days ending on the trading day immediately prior to the date on which the Company provides notice of such redemption exceeds 150% of the applicable conversion price in effect on each such trading day, at a redemption price equal to 100% of the principal amount of notes being redeemed, together with accrued and unpaid interest to, but not including, the redemption date (as defined in the Indenture).
	In connection with the sale of the Notes, the Company entered into a registration rights agreement, dated as of May 6, 2014, with the Purchasers, or the Registration Rights Agreement, providing for customary resale registration rights with respect to the Notes and the ordinary shares issuable upon conversion of the Notes, if any.
	Term Loan and Revolving Credit Facility
	In connection with the completion of our acquisition of LSI on May 6, 2014, our subsidiaries Avago Technologies Finance Pte. Ltd., or AT Finance, Avago Technologies Cayman Ltd., or AT Cayman, Avago Technologies Holdings Luxembourg S.àr.l ("AT Luxco" and, together with AT Cayman, the "Borrowers"), together a group of lenders, including Deutsche Bank AG New York Branch as the Administrative Agent, entered into the 2014 Credit Agreement. The 2014 Credit Agreement provides for a term loan facility in the aggregate principal amount of $4.6 billion and a revolving credit facility that permits the Borrowers to borrow loans from time to time in an aggregate principal amount of up to $500 million, for general corporate purposes, for swingline loans of up to $75 million in the aggregate and for the issuance of letters of credit of up to $100 million in the aggregate, which, in the case of swingline loans and letters of credit, reduce the available borrowing capacity under the revolving credit facility on a dollar for dollar basis. The Borrowers’ obligations under the 2014 Credit Agreement are guaranteed by AT Finance and certain of its subsidiaries, or the Subsidiary Guarantors, and are collateralized, subject to certain exceptions, by all the assets of AT Finance, each Borrower, and each Subsidiary Guarantor. The term loan facility has a term of 7 years and the revolving credit facility has a term of 5 years.
	Loans under the 2014 Credit Agreement will bear interest at a rate per annum equal to (i) to the greatest of (a) the rate of interest per annum publicly announced from time to time by Deutsche Bank AG New York Branch as its prime rate in effect at its principal office in New York City, (b) the Federal Funds Effective Rate (as defined in the 2014 Credit Agreement) in effect on such day plus 1/2 of 1% per annum, (c) the Adjusted LIBO Rate (as defined in the Credit Agreement) on such day for a deposit in dollars with a maturity of one month plus 1% per annum and (d), with respect to term loans, 1.75% or (ii) the interest rate per annum equal to the greater of (a) (x) the LIBO Rate for such Interest Period multiplied by (y) the Statutory Reserve Rate (as defined in the 2014 Credit Agreement) and (b) with respect to term loans, 0.75% per annum.
	The 2014 Credit Agreement includes (i) financial covenants requiring AT Finance to, at any time the revolving credit facility is drawn by more than 30%, maintain a maximum first lien leverage ratio; (ii) customary restrictive covenants (subject, in each case, to certain exceptions and amounts) that limit AT Finance and its subsidiaries’ ability to, among other things, incur indebtedness, create liens, merge or consolidate with and into other persons, make acquisitions and sell assets; (iii) customary events of default, upon the occurrence of which, after any applicable grace period, the lenders will have the ability to accelerate all outstanding loans thereunder and terminate the commitments; and (iv) customary representations and warranties. In addition, AT Finance has the ability, at any time, to increase the aggregate term loans and revolving credit commitments under the 2014 Credit Agreement from $5.1 billion to $6.7 billion, subject to the condition that no default or event of default shall have occurred and be continuing and other terms and conditions set forth in the 2014 Credit Agreement, and the receipt of sufficient commitments for such increase from the lenders.
	The Borrowers have agreed to pay the lenders a commitment fee at a rate per annum that varies based on total leverage ratio. The Borrowers also entered into collateral and related agreements ancillary to the 2014 Credit Agreement.
	LSI Acquisition-Related Restructuring Plan
	On May 13, 2014, we began the implementation of planned cost reduction and restructuring activities following the acquisition of LSI. As part of this plan we expect to eliminate approximately 1,100 positions from the combined workforce across all business and functional areas on a global basis.
	Pending Sale of the LSI Flash Component Division and Accelerated Solutions Division
	On May 29, 2014, our subsidiary LSI Corporation entered into an Asset Purchase Agreement with Seagate Technology LLC, or Seagate, pursuant to which LSI Corporation has agreed to sell its Flash Components Division and Accelerated Solutions Division to Seagate for $450 million in cash. Each of the parties has made customary representations and warranties in the Asset Purchase Agreement. Consummation of the transaction is subject to the satisfaction or waiver of customary closing conditions and receipt of certain regulatory approvals, including the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is presently expected to close in the third calendar quarter of 2014.
	Cash Dividends
	On June 4, 2014, the Board declared an interim cash dividend on the Company’s ordinary shares of $0.29 per share, payable on June 30, 2014 to shareholders of record at the close of business (5:00 p.m.), Eastern Time, on June 19, 2014.

Overview_and_Basis_of_Presenta1

Overview and Basis of Presentation (Policies)	6 Months Ended
Overview and Basis of Presentation (Policies)	4-May-14
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Cash Flow, Supplemental Disclosures [Text Block]	'
Cash Flow, Supplemental Disclosures [Text Block]	Supplemental cash flow disclosures. At May 4, 2014 and November 3, 2013, we had $43 million and $31 million, respectively, of unpaid purchases of property, plant, and equipment included in accounts payable and other current liabilities. Amounts reported as unpaid purchases will be recorded as cash outflows from investing activities for purchases of property, plant, and equipment in the unaudited condensed consolidated statement of cash flows for the period in which they are paid.
Fiscal Periods	'
Fiscal Periods	Fiscal Periods. We operate on a 52- or 53-week fiscal year ending on the Sunday closest to October 31. Our fiscal year ending November 2, 2014, or fiscal year 2014, is a 52-week fiscal year. The first quarter of our fiscal year 2014 ended on February 2, 2014, the second quarter ended on May 4, 2014, the third quarter will end on August 3, 2014 and the fourth quarter will end on November 2, 2014. Our fiscal year ended November 3, 2013, or fiscal year 2013, was a 53-week fiscal year, with our first fiscal quarter containing 14 weeks.
Information	'
	Information. The unaudited condensed consolidated financial statements include the accounts of Avago Technologies Limited and all of its wholly-owned subsidiaries, and are prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP. Intercompany transactions and balances have been eliminated in consolidation.
	During fiscal year 2013, we completed our acquisition of CyOptics, Inc., or CyOptics. The unaudited condensed consolidated financial statements include the results of operations of CyOptics commencing as of the closing date of the acquisition. (See Note 3. "Acquisitions and Investment")
	Interim information presented in the unaudited condensed consolidated financial statements has been prepared by management and, in the opinion of management, includes all adjustments of a normal recurring nature that are necessary for the fair statement of the financial position, results of operations, comprehensive income and cash flows for the periods shown, and is in accordance with GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the fiscal year ended November 3, 2013, or fiscal year 2013, included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission, or the SEC, on December 20, 2013.
	The operating results for the fiscal quarter and two fiscal quarters ended May 4, 2014 are not necessarily indicative of the results that may be expected for fiscal year 2014, or for any other future period. The balance sheet data as of November 3, 2013 presented are derived from the audited consolidated financial statements as of that date.
Use of estimates	'
Use of estimates	Use of estimates. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, and such differences could affect the results of operations reported in future periods.
Concentration Risk and Significant Customers, Policy [Policy Text Block]	'
	Concentrations of credit risk and significant customers. Our cash, cash equivalents and accounts receivable are potentially subject to concentration of credit risk. Cash and cash equivalents may be redeemable upon demand and are maintained with several financial institutions that management believes are of high credit quality and therefore bear minimal credit risk. We seek to mitigate our credit risks by spreading such risks across multiple counterparties and monitoring the risk profile of these counterparties. Our accounts receivable are derived from revenue earned from customers located in the U.S. and internationally. We mitigate collection risks from our customers by performing regular credit evaluations of our customers' financial conditions, and require collateral, such as letters of credit and bank guarantees, in certain circumstances.
	We sell our products through our direct sales force, distributors and manufacturers' representatives. Two direct customers accounted for 19% and 10%, respectively, of our net accounts receivable balance at May 4, 2014. One direct customer accounted for 26% of our net accounts receivable balance at November 3, 2013. For the fiscal quarter ended May 4, 2014, two direct customers represented 14% and 13% of our net revenue, respectively. For the fiscal quarter ended May 5, 2013, two direct customers represented 16% and 10% of our net revenue, respectively. For the two fiscal quarters ended May 4, 2014, two direct customers represented 20% and 10% of our net revenue, respectively. For the two fiscal quarters ended May 5, 2013, one direct customer represented 18% of our net revenue.
Standard Product Warranty, Policy [Policy Text Block]	'
Standard Product Warranty, Policy [Policy Text Block]	Warranty. We accrue for the estimated costs of product warranties at the time revenue is recognized. Product warranty costs are estimated based upon our historical experience and specific identification of product requirements, which may fluctuate based on product mix. Additionally, we accrue for warranty costs associated with occasional or unanticipated product quality issues if a loss is probable and can be reasonably estimated. Warranty costs were not material for either of the fiscal quarter or the two quarters ended May 4, 2014 or May 5, 2013.
Segment Reporting, Policy [Policy Text Block]	'
Segment Reporting, Policy [Policy Text Block]	ASC 280 “Segment Reporting,” or ASC 280, establishes standards for the way public business enterprises report information about operating segments in annual consolidated financial statements and requires that those enterprises report selected information about operating segments in interim financial reports. ASC 280 also establishes standards for related disclosures about products and services, geographic areas and major customers. We completed the CyOptics acquisition in the third quarter of fiscal year 2013 and have fully integrated CyOptics into Avago's organization structure and business model. Therefore, we have concluded that we continue to have one reportable segment based on the following factors: sales of semiconductors represents our only material source of revenue; substantially all products offered incorporate analog functionality and are manufactured under similar manufacturing processes; we use an integrated approach in developing our products in that discrete technologies developed are frequently integrated across many of our products; and we use a common order fulfillment process and similar distribution approach for our products. Broad distributor networks are typically used to distribute our products, with large accounts being serviced by a direct sales force. The Chief Executive Officer has been identified as the Chief Operating Decision Maker, as defined by ASC 280.
Net income per share	'
	Net income per share. Basic net income per share is computed using the weighted-average number of ordinary shares outstanding during the period. Diluted net income per share is computed using the weighted-average number of ordinary shares and potentially dilutive share equivalents outstanding during the period. Diluted shares outstanding includes the dilutive effect of in-the-money options (including market-based share options), restricted share units, or RSUs, and employee share purchase rights under the Avago Technologies Limited Employee Share Purchase Plan, or ESPP. The dilutive effect of such equity awards is calculated based on the average share price for each fiscal period, using the treasury stock method. Under the treasury stock method, the amount the employee must pay for exercising share options and to purchase shares under the ESPP, the amount of compensation cost for future service that the Company has not yet recognized, and the amount of tax benefits that would be recorded in an ordinary shares account when equity awards become deductible for income tax purposes are collectively assumed to be used to repurchase ordinary shares.
	Diluted net income per share for the fiscal quarter and two fiscal quarters ended May 4, 2014 and the fiscal quarter and two fiscal quarters ended May 5, 2013 excluded the potentially dilutive effect of weighted-average outstanding equity awards (options, RSUs and ESPP rights) to acquire 1 million, 0 million, 2 million and 2 million ordinary shares, respectively, as their effect was antidilutive.
Recent Accounting Guidance	'
	Recently Adopted Accounting Guidance
	In the first quarter of fiscal year 2014, we adopted guidance issued by the Financial Accounting Standards Board, or FASB, relating to reporting on reclassifications out of accumulated other comprehensive income (loss). This guidance seeks to improve the reporting of such reclassifications by requiring an entity to report the effect of significant reclassifications out of accumulated other comprehensive income (loss) on the respective line items in net income if the amount being reclassified is required under GAAP to be reclassified in its entirety to net income. For other amounts that are not required under GAAP to be reclassified in their entirety to net income in the same reporting period, an entity is required to cross-reference other disclosures required under GAAP that provide additional detail about those amounts. The amendments in this guidance supersede the presentation requirements for reclassifications out of accumulated other comprehensive income (loss) in previously issued guidance. The adoption of this guidance affected the presentation of comprehensive income, but did not have any impact our financial condition or results of operations.
	Recent Accounting Guidance Not Yet Adopted
	In May 2014, the FASB and International Accounting Standards Board issued their converged standard on revenue recognition. The core principle of the new standard is for companies to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration (that is, payment) to which the company expects to be entitled in exchange for those goods or services. The new standard also will result in enhanced disclosures about revenue, provide guidance for transactions that were not previously addressed comprehensively (for example, service revenue and contract modifications) and improve guidance for multiple-element arrangements. This guidance will be effective for the first quarter of our fiscal year 2018. The Company is currently evaluating the impact that this guidance will have on its financial condition and results of operations.
	In April 2014, the FASB issued authoritative guidance that raises the threshold for a disposal transaction to qualify as a discontinued operation and requires additional disclosures about discontinued operations and disposals of individually significant components that do not qualify as discontinued operations. This guidance will be effective prospectively for the first quarter of our fiscal year 2016. Early adoption is permitted, but only for disposals that have not been reported in financial statements previously issued. The Company is evaluating the impact, if any, that this guidance will have on its financial condition or results of operations.
	In July 2013, the FASB issued an amendment to the accounting guidance related to the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists. The guidance requires an unrecognized tax benefit to be presented as a decrease in a deferred tax asset where a net operating loss, a similar tax loss or a tax credit carryforward exists and certain criteria are met. This guidance will be effective for the first quarter of our fiscal year 2015. The adoption of this guidance will affect the presentation of our unrecognized tax benefits but will not impact the Company's financial condition or results of operations.

Overview_and_Basis_of_Presenta2

Overview and Basis of Presentation (Tables)	6 Months Ended
	4-May-14
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Reconciliation of the denominators of the basic and diluted net income per share	'
	The following is a reconciliation of the basic and diluted net income per share computations for the periods presented (in millions, except per share data):


		Fiscal Quarter Ended				Two Fiscal Quarters Ended
		May 4,		May 5,		May 4,		May 5,
		2014		2013		2014		2013
	Net income (Numerator):
	Net income	$	158	$	113	$	292	$	238

	Shares (Denominator):
	Basic weighted-average ordinary shares outstanding	251		246		250		246

	Add incremental shares for:
	Dilutive effect of share options, RSUs and ESPP rights	7		5		6		5

	Shares used in diluted computation	258		251		256		251

	Net income per share:
	Basic	$	0.63	$	0.46	$	1.17	$	0.97

	Diluted	$	0.61	$	0.45	$	1.14	$	0.95

Inventory_Tables

Inventory (Tables)	6 Months Ended
	4-May-14
Inventory Disclosure [Abstract]	'
Summary of inventory	'
	Inventory consists of the following (in millions):


		May 4, 2014		November 3, 2013
	Finished goods	$	60	$	53

	Work-in-process	156		154

	Raw materials	85		78

	Total inventory	$	301	$	285

Acquisitions_Acquisitions_Tabl

Acquisitions Acquisitions (Tables)	6 Months Ended
	4-May-14
Business Combinations [Abstract]	'
Business Acquisition, Pro Forma Information [Table Text Block]	'


		Fiscal Year Ended
		3-Nov-13				28-Oct-12
	Pro forma net revenue	$	2,663			$	2,578

	Pro forma net income	$	547			$	551

	Pro forma net income per share-basic	$	2.21			$	2.25

	Pro forma net income per share-diluted	$	2.17			$	2.2

Schedule of Purchase Price Allocation [Table Text Block]	'
	Our allocation of the total purchase price for CyOptics and the purchased intangible assets as of May 4, 2014 is as follows (in millions):


		Fair Value
	Trade accounts receivable	$	51

	Inventory	35

	Other current assets	2

	Property, plant and equipment	44

	Goodwill	190

	Intangible assets	141

	Total assets acquired	463

	Accounts payable	(25		)
	Employee compensation and benefits	(5		)
	Other current liabilities	(2		)
	Long-term deferred tax liabilities (included in Other long-term liabilities)	(54		)
	Total liabilities assumed	(86		)
	Purchase price allocation	$	377

Schedule of Finite and Indefinite Lived Intangible Assets Acquired as part of Business Combination [Table Text Block]	'


		Fair Value			Estimated Useful
		(in millions)			Lives (in years)
	Purchased intangible assets
	Purchased technology - base product	$	98		8

	Purchased technology - packaging	3			5

	Customer relationships	32			7

	Other - customer backlog	4			1

	Total identified intangible finite lived assets	137

	In process research and development indefinite lived assets	4

	Total identified intangible assets	$	141

Acquisitions and Investments [Text Block]	'
	Acquisitions and Investment

	LSI Corporation
	On May 6, 2014, subsequent to the end of our second fiscal quarter, which ended on May 4, 2014, we completed our previously announced acquisition of all of the issued and outstanding shares of common stock of LSI Corporation, or LSI, a U.S. publicly traded company that designs semiconductors that accelerate storage and networking in data centers, mobile networks and client computing, for an aggregate acquisition consideration of approximately $6.5 billion in cash, or $11.15 in cash per share of LSI common stock. (See Notes 6. "Borrowings" and 15. "Subsequent Events" for further details.)
	CyOptics
	On June 28, 2013, we completed our acquisition of all of the outstanding shares of capital stock of CyOptics, a U.S.-based company that manufactures and sells Indium Phosphide, or InP, optical chip and component technologies for the data communications and telecommunications markets. CyOptics has front-end manufacturing operations in the U.S. and back-end manufacturing operations in Mexico. As a result of the CyOptics acquisition, we acquired approximately 1,100 additional employees, with 745 of these employees located in Mexico.
	The aggregate consideration for the acquisition was approximately $377 million of which $373 million was paid in cash, net of $3 million in cash acquired. We also agreed to pay additional deferred consideration to the previous shareholders of CyOptics in the amount of $4 million one year subsequent to the acquisition date, which was recorded in other current liabilities.
	An additional approximately $27 million is payable to key employees of CyOptics as part of a retention bonus plan. This amount was paid into escrow and will be paid to those employees over a three-year period subsequent to the acquisition date and is being recognized as compensation expense in operating results over the same period. For eligible CyOptics employees whose employment is involuntarily terminated by the Company, their retention bonus payments are accelerated and due in full upon such termination in accordance with the provisions of the plan. During the fiscal quarter and two fiscal quarters ended May 4, 2014, we recorded a compensation expenses of $1 million and $10 million, respectively, due to the departures of certain plan participants.
	We have preliminarily estimated the fair value of the acquired assets and liabilities for CyOptics. We allocated the purchase price to tangible assets, liabilities and identifiable intangible assets acquired based on their estimated fair values. The excess of the purchase price over the aggregate fair values was recorded as goodwill. The fair value assigned to identifiable intangible assets acquired was based on estimates and assumptions made by management at the time of acquisition. As additional information becomes available, such as finalization of negotiations of working capital adjustments and tax related matters, we have revised and may continue to revise our preliminary purchase price allocation.
	Our allocation of the total purchase price for CyOptics and the purchased intangible assets as of May 4, 2014 is as follows (in millions):


		Fair Value
	Trade accounts receivable	$	51

	Inventory	35

	Other current assets	2

	Property, plant and equipment	44

	Goodwill	190

	Intangible assets	141

	Total assets acquired	463

	Accounts payable	(25		)
	Employee compensation and benefits	(5		)
	Other current liabilities	(2		)
	Long-term deferred tax liabilities (included in Other long-term liabilities)	(54		)
	Total liabilities assumed	(86		)
	Purchase price allocation	$	377

	There were no significant contingencies assumed as part of the acquisition. As of May 4, 2014, we have a $12 million indemnification receivable in other long-term assets for tax positions related to CyOptics' value-added tax and income tax payables existing prior to the acquisition.


		Fair Value			Estimated Useful
		(in millions)			Lives (in years)
	Purchased intangible assets
	Purchased technology - base product	$	98		8

	Purchased technology - packaging	3			5

	Customer relationships	32			7

	Other - customer backlog	4			1

	Total identified intangible finite lived assets	137

	In process research and development indefinite lived assets	4

	Total identified intangible assets	$	141

	Purchased Intangible Assets. Developed technology represents base product technology and packaging technology. We valued the base product technology that generates cash flows from sales of the existing products using the income approach, specifically the multi-period excess earnings method which calculates the value based on the risk-adjusted present value of the cash flows specific to the products, allowing for a reasonable return. The useful life of 8 years was determined based on the technology cycle related to the base product technology as well as the life of current legacy products.
	Packaging technology is valued utilizing the relief-from-royalty method, a form of the income approach. The relief-from-royalty method estimates the cost savings that accrue to the owner of an intangible asset that would otherwise be payable as royalties or license fees on revenues earned through the use of the asset. The royalty rate is based on an analysis of empirical, market-derived royalty rate for guideline intangible assets.
	Customer relationships represent the fair value of future projected revenue that will be derived from sales of products to existing customers of CyOptics. Customer relationships were valued using the with-and-without-method, a form of the income approach. In this method, fair value is measured by the lost profits associated with the period of time necessary to reacquire the customers. The method involves a comparison of the cash flows assuming the customer relationships were in place versus as if the customer relationships were to be created "from scratch." There are additional considerations related to the build-in time for certain product lines and the qualification periods included in the valuation model. This method also assumes that all other assets, know-how and technology were easily available in both scenarios.
	The fair value of in-process research and development, or IPR&D, from the CyOptics acquisition was determined using the multi-period excess earnings method, a form of the income approach. Under the income approach, the expected future cash flows from each project under development are estimated and discounted to their net present values at an appropriate risk-adjusted rate of return.
	We believe the amount recorded as developed technology, IPR&D and customer relationships, represent the fair value of and approximate the amount a market participant would pay for these projects as of the acquisition date.
	The purchased intangible assets are being amortized over their estimated useful lives of 1 year to 8 years. (See Note 4. Goodwill and Intangible Assets)
	Unaudited Pro Forma Information. The following table presents certain unaudited pro forma financial information for each of the fiscal years ended November 3, 2013 and October 28, 2012 as if CyOptics had been acquired as of the beginning of the fiscal year prior to the acquisition date. The unaudited estimated pro forma information combines the historical results of CyOptics with our consolidated historical results and includes certain fair value adjustments reflecting the estimated impact of amortization of purchased intangible assets and depreciation of acquired property, plant and equipment for the respective periods. The pro forma data are for informational purposes only and are not necessarily indicative of the consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of our fiscal year 2012 or of the results of future operations of the combined business. Consequently, actual results will differ from the unaudited pro forma information presented below (in millions, except for per share amounts):


	Fiscal Year Ended
	3-Nov-13				28-Oct-12
Pro forma net revenue	$	2,663			$	2,578

Pro forma net income	$	547			$	551

Pro forma net income per share-basic	$	2.21			$	2.25

Pro forma net income per share-diluted	$	2.17			$	2.2

Investment
In fiscal year 2013, we made a minority equity investment of $9 million in the common stock of a U.S. publicly traded company, which we accounted for as a trading security. In the fiscal quarter ended May 4, 2014, we completely exited our investment in the shares of this company. As a result, for the quarter and two fiscal quarters ended May 4, 2014, we realized an immaterial loss from the sale of the shares which was recorded in other income, net in the unaudited condensed consolidated statements of operations.

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Tables)	6 Months Ended
	4-May-14
Finite-Lived Intangible Assets [Line Items]	'
Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]	'
	Purchased intangibles consist of the following (in millions):


		Gross Carrying		Accumulated			Net Book Value
		Amount		Amortization
	As of May 4, 2014:
	Purchased technology	$	843	$	(498	)	$	345

	Customer and distributor relationships	289		(199		)	90

	Other	8		(6		)	2

	Intangible assets subject to amortization	1,140		(703		)	437

	In-process research and development	4		—			4

	Total	$	1,144	$	(703	)	$	441


	As of November 3, 2013:
	Purchased technology	$	843	$	(462	)	$	381

	Customer and distributor relationships	289		(186		)	103

	Other	8		(4		)	4

	Intangible assets subject to amortization	1,140		(652		)	488

	In-process research and development	4		—			4

	Total	$	1,144	$	(652	)	$	492

Finite-lived Intangible Assets Amortization Expense [Table Text Block]	'
	The following table presents the amortization expense of purchased intangible assets (in millions):


		Fiscal Quarter Ended					Two Fiscal Quarters Ended
		May 4,		May 5,			May 4,		May 5,
		2014		2013			2014		2013
	Cost of products sold	$	18	$	14		$	36	$	28

	Operating expenses	8		6			15		11

	Total amortization expense	$	26	$	20		$	51	$	39

Finite Lived Intangible Assets Remaining [Table Text Block]	'
	Based on the amount of intangible assets subject to amortization at May 4, 2014, the expected amortization expense for each of the next five fiscal years and thereafter is as follows (in millions):


	Fiscal Year	Amount
	2014 (remainder)	$	49

	2015	95

	2016	78

	2017	68

	2018	33

	2019	29

	Thereafter	85

		$	437

Finite Lived Intangible Assets Remaining Weighted Average Amortization Period [Table Text Block]	'
	The weighted-average amortization periods remaining by intangible asset category at May 4, 2014 were as follows (in years):


	Amortizable intangible assets:
	Purchased technology	7
	Customer and distributor relationships	6
	Other	13

Fair_Value_Tables

Fair Value (Tables)	6 Months Ended
	4-May-14
Fair Value Disclosures [Abstract]	'
Financial assets measured at fair value on a recurring basis	'
	The table below sets forth by level our financial assets and liabilities that were accounted for at fair value as of May 4, 2014. The table does not include cash on hand and also does not include assets that are measured at historical cost or any basis other than fair value (in millions).


		As of May 4, 2014
		Portion of Carrying		Fair Value		Fair Value Measurement Using Significant Other Inputs (Level 2)		Fair Value Measurement
		Value Measured at Fair		Measurement Using				Using Unobservable Inputs
		Value		Quoted Prices				(Level 3)
				In Active Market
				For Identical
				Assets
				(Level 1)
	Assets:
	Investment funds — deferred compensation plan assets (1)	$	12	$	12	$	—	$	—

	Bank acceptances (1)	1		1		—		—

	Total assets measured at fair value	$	13	$	13	$	—	$	—

	Liabilities:
	Deferred compensation plan liabilities (2)	$	12	$	—	$	12	$	—

	_________________________________


	-1	Included in other current assets in our unaudited condensed consolidated balance sheet

	-2	Included in other current liabilities in our unaudited condensed consolidated balance shee

Shareholders_Equity_Tables

Shareholders' Equity (Tables)	6 Months Ended
	4-May-14
Equity [Abstract]	'
Summary of share-based compensation expense related to share-based awards granted to employees, directors, and non-employees	'
	The following table summarizes share-based compensation expense related to share-based awards granted to employees, directors, and non-employees for the fiscal quarter and two fiscal quarters ended May 4, 2014 and May 5, 2013 (in millions):


		Fiscal Quarter Ended								Two Fiscal Quarters Ended
		May 4,				May 5,				May 4,			May 5,
		2014				2013				2014			2013
	Cost of products sold	$	3			$	2			$	6		$	4

	Research and development	10				7				18			14

	Selling, general and administrative	17				8				30			17

	Total share-based compensation expense	$	30			$	17			$	54		$	35

Weighted average assumptions of stock options	'
	The fair values of our time-based options and ESPP rights were estimated using the Black-Scholes option pricing model. Certain stock options granted in the fiscal quarter and two fiscal quarters ended May 4, 2014 and May 5, 2013, respectively, included both service and market conditions. The fair value of those market-based stock options was estimated using Monte Carlo simulation techniques.
	The weighted-average assumptions utilized for our time-based options, ESPP rights and share price performance options, also referred to as market-based options granted during the fiscal quarter and two fiscal quarters ended May 4, 2014 and May 5, 2013 were as follows:


		Time-Based Options
		Fiscal Quarter Ended						Two Fiscal Quarters Ended
		May 4,			May 5,			May 4,			May 5,
		2014			2013			2014			2013
	Risk-free interest rate	1.3	%		0.9	%		1.3	%		0.9	%
	Dividend yield	1.7	%		1.9	%		1.8	%		1.9	%
	Volatility	35	%		48	%		35	%		49	%
	Expected term (in years)	4.3			5			4.2			5



		Market-Based Options
		Fiscal Quarter Ended						Two Fiscal Quarters Ended
		May 4,			May 5,			May 4,			May 5,
		2014			2013			2014			2013
	Risk-free interest rate	2.3	%		1.4	%		2.3	%		1.4	%
	Dividend yield	1.7	%		1.9	%		1.8	%		1.9	%
	Volatility	45	%		50	%		45	%		50	%
	Expected term (in years)	7			7			7			7

Weighted average assumptions of employee share purchase plan	'


		ESPP Rights
		Fiscal Quarter Ended						Two Fiscal Quarters Ended
		May 4,			May 5,			May 4,			May 5,
		2014			2013			2014			2013
	Risk-free interest rate	0.1	%		0.1	%		0.1	%		0.1	%
	Dividend yield	1.7	%		2.1	%		2	%		2	%
	Volatility	31	%		46	%		34	%		45	%
	Expected term (in years)	0.5			0.5			0.5			0.5

Summary of share based payment award activity	'
	A summary of option award activity related to our equity incentive plans is as follows (in millions, except years and per share amounts):


					Option Awards Outstanding
		Shares			Number			Weighted-				Weighted-	Aggregate
		Available			Outstanding			Average				Average	Intrinsic
		for Grant						Exercise Price				Remaining	Value
								Per Share				Contractual
												Life (in years)
	Balance as of November 3, 2013	10			22			$	29.81

	Annual increase in shares available for issuance, per equity incentive plan terms	6

	Granted	(7	)		7			59.56

	Exercised	—			(2	)		24.28

	Cancelled	—			—			36.67

	Balance as of May 4, 2014	9			27			37.82				5.65	$	705

	Fully vested as of May 4, 2014				8			23.7				4.82	339

	Fully vested and expected to vest as of
	4-May-14				25			37.14				5.61	682

Schedule of Other Share-based Compensation, Activity [Table Text Block]	'
	A summary of RSU activity related to our equity incentive plans is as follows (in millions, except years and per share amounts):


			RSU Awards Outstanding
			Number			Weighted-				Weighted-
			Outstanding			Average				Average
						Grant Date				Remaining
						Fair Market Value				Contractual
										Life (in years)
	Balance as of November 3, 2013		2			$	34.38

	Granted		1			59.02

	Vested		(1	)		33.89

	Forfeited		—			39.04

	Balance as of May 4, 2014		2			43.05				3.16

Ranges of outstanding and exercisable awards	'
	The following table summarizes the ranges of outstanding and exercisable option awards as of May 4, 2014 (in millions, except years and per share amounts):


			Option Awards Outstanding									Option Awards Exercisable
	Exercise Prices		Number Outstanding			Weighted-		Weighted-Average				Number Exercisable		Weighted-Average
						Average		Exercise Price Per Share						Exercise Price Per Share
						Remaining
						Contractual
						Life (in years)
	$0.00-$10.00		1			4.06		$	8.47			1		$	8.49

	$10.01-$20.00		2			4.55		13.31				2		13.33

	$20.01-$30.00		2			6.16		21				1		20.86

	$30.01-$40.00		15			5.34		35.48				4		34.19

	$40.01-$50.00		1			6.47		45.56				—		—

	$50.01-$60.00		1			6.69		53.57				—		—

	$60.01-$63.18		5			6.84		62.01				—		—

	Total		27			5.65		37.82				8		23.7

Related_Party_Transactions_Tab

Related Party Transactions (Tables)	6 Months Ended
	4-May-14
Related Party Transactions [Abstract]	'
Transactions and balances with related parties	'


		Fiscal Quarter Ended						Two Fiscal Quarters Ended
		May 4,			May 5,			May 4,			May 5,
		2014			2013			2014			2013
	Total net revenue (1) (2)	$	—		$	10		$	—		$	16

	Total costs and expenses (2)	—		*	1			—		*	2



		May 4,			November 3,
		2014			2013
	Total receivables	$	—		$	—	*

	Total payables	—		*	—		*

	_________________________________
	* Represent amounts less than $0.5 million.
	(1) Amounts include net revenue for related party transactions with Wistron Corporation through the fiscal quarter ended May 5, 2013. Wistron Corporation ceased to be a related party after the fiscal quarter ended August 4, 2013.
	(2) Amounts include net revenue, cost and expenses for related party transactions with eSilicon Corporation through the fiscal quarter ended May 5, 2013. eSilicon Corporation ceased to be a related party after the fiscal quarter May 5, 2013.
	Convertible Senior Notes
	On December 15, 2013, in connection with our acquisition of LSI, the Company entered into a Note Purchase Agreement with Silver Lake Partners IV, L.P, or SLP IV as the Purchaser and Deutsche Bank, A.G., Singapore Branch, as Lead Manager, referred to as the Note Purchase Agreement, in connection with the private placement of $1 billion aggregate principal amount of the Company's 2.0% Convertible Senior Notes due 2021. Silver Lake Partners IV an investment fund affiliated with Silver Lake Partners, of which Kenneth Hao, one of our directors, is a Managing Director. Mr. Hao disclaims all beneficial interest in the Notes, except to the extent of his pecuniary interest therein. We completed the private placement of the Notes on May 6, 2014, in connection with the completion of the acquisition of LSI. See Note 6. "Borrowings" for additional details.

Commitments_And_Contingencies_

Commitments And Contingencies (Tables)	6 Months Ended
	4-May-14
Commitments and Contingencies Disclosure [Abstract]	'
Changes in commitments	'
	The following table sets forth changes in our commitments as of May 4, 2014 for the fiscal periods noted (in millions):


		Total		2014 (remainder)		2015		2016		2017		2018		2019		Thereafter
	Purchase Commitments	$	216	$	216	$	—	$	—	$	—	$	—	$	—	$	—

	Other Contractual Commitments	$	50	$	11	$	16	$	13	$	6	$	4	$	—	$	—

Restructuring_charges_Tables

Restructuring charges (Tables)	6 Months Ended
	4-May-14
Restructuring and Related Activities [Abstract]	'
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	'


		Employee Termination Cost		Asset Abandonment Costs		Other		Total
	Balance as of November 3, 2013	$	—	$	—	$	—	$	—

	Cost of product sold	5		—		—		5

	Operating expenses	17		2		1		20

	Less: Non-cash portion	—		2		—		2

	Less: Cash payments	4		—		1		5

	Accrued balance as of May 4, 2014 - included in Other current liabilities	$	18	$	—	$	—	$	18

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Income (Loss) (Tables)	6 Months Ended
	4-May-14
Equity [Abstract]	'
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
	The change in accumulated other comprehensive income (loss) by component and related tax effects for the period below is as follows (in millions):


		Prior Service Credits (Cost)			Actuarial Gains (Losses)			Total
	Balance as of November 3, 2013	$	(1	)	$	(5	)	$	(6	)
	Other comprehensive income (loss) before reclassifications	1			—			1

	Amounts reclassified out of accumulated other comprehensive loss	(1		)	(2		)	(3		)
	Tax effects	—			1			1

	Other comprehensive loss	—			(1		)	(1		)

	Balance as of May 4, 2014	$	(1	)	$	(6	)	$	(7	)
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	'
	The amounts reclassified out of accumulated other comprehensive income (loss) into the unaudited condensed consolidated statements of operations, with presentation location, during each period were as follows (in millions):


			Fiscal Quarter Ended						Fiscal Two Quarters Ended
	Comprehensive Income Components		May 4,			May 5,			May 4,		May 5,		Classified to:
			2014			2013			2014		2013
	Post-retirement benefit amendment, curtailment and settlement gain, net		$	—		$	—		$	1	$	—	Cost of products sold

	Post-retirement benefit amendment, curtailment and settlement gain, net		—			—			1		—		Research and development

	Post-retirement benefit amendment, curtailment and settlement gain, net		—			—			1		—		Selling, general and administrative

	Total amounts reclassified out of accumulated other comprehensive income (loss)		$	—		$	—		$	3	$	—

Overview_and_Basis_of_Presenta3

Overview and Basis of Presentation (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, except Per Share data, unless otherwise specified	4-May-14	5-May-13	4-May-14	5-May-13
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1	2	0	2
Net income (Numerator):	'	'	'	'
Net income	$158	$113	$292	$238
Shares (Denominator):	'	'	'	'
Weighted Average Number of Shares Outstanding, Basic	251	246	250	246
Add: Incremental shares for:	'	'	'	'
Dilutive effect of share options, RSUs and ESPP rights	7	5	6	5
Shares used in diluted computation	258	251	256	251
Net income per share:	'	'	'	'
Earnings Per Share, Basic	$0.63	$0.46	$1.17	$0.97
Earnings Per Share, Diluted	$0.61	$0.45	$1.14	$0.95

Overview_and_Basis_of_Presenta4

Overview and Basis of Presentation (Details Textuals) (USD $)	3 Months Ended			6 Months Ended		12 Months Ended
In Millions, except Per Share data, unless otherwise specified	4-May-14	Nov. 03, 2013	5-May-13	4-May-14	5-May-13	Nov. 03, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1	'	2	0	2	'
Net Income (Loss) Attributable to Parent	$158	'	$113	$292	$238	'
Capital Expenditures Incurred but Not yet Paid	$43	$31	'	'	'	'
Fiscal period end	'	'	'	'364 days	'	'371 days
Weighted Average Number of Shares Outstanding, Basic	251	'	246	250	246	'
Weighted Average Number Diluted Shares Outstanding Adjustment	7	'	5	6	5	'
Weighted Average Number of Shares Outstanding, Diluted	258	'	251	256	251	'
Earnings Per Share, Basic	$0.63	'	$0.46	$1.17	$0.97	'
Earnings Per Share, Diluted	$0.61	'	$0.45	$1.14	$0.95	'
Accounts Receivable [Member]	'	'	'	'	'	'
Number of customers accounting for 10% or more	'	'	'	2	'	1
Accounts Receivable [Member] \| Major Customer One [Member]	'	'	'	'	'	'
Concentration Risk, Percentage	'	'	'	19.00%	'	26.00%
Accounts Receivable [Member] \| Major Customer Two	'	'	'	'	'	'
Concentration Risk, Percentage	'	'	'	10.00%	'	'
Sales [Member]	'	'	'	'	'	'
Number of customers accounting for 10% or more	2	'	2	2	1	'
Sales [Member] \| Major Customer One [Member]	'	'	'	'	'	'
Concentration Risk, Percentage	14.00%	'	16.00%	20.00%	18.00%	'
Sales [Member] \| Major Customer Two	'	'	'	'	'	'
Concentration Risk, Percentage	13.00%	'	10.00%	10.00%	'	'

Inventory_Details

Inventory (Details) (USD $)	4-May-14	Nov. 03, 2013
In Millions, unless otherwise specified	4-May-14	Nov. 03, 2013
Inventory Disclosure [Abstract]	'	'
Finished goods	$60	$53
Work-in-process	156	154
Raw materials	85	78
Total inventory	$301	$285	[1]

[1]	Amounts as of NovemberÂ 3, 2013 have been derived from audited consolidated financial statements as of that date.

Acquisitions_Pending_Acqusitio

Acquisitions Pending Acqusition - LSI Corporation (Details) (Subsequent Event [Member], LSI acquisition [Member], USD $)	0 Months Ended
	6-May-14
Subsequent Event [Member] \| LSI acquisition [Member]	'
Business Acquisition [Line Items]	'
Preliminary purchase price related to LSI acquisition	$6,500,000,000
Business Acquisition, Share Price	$11.15
Principal Amount basis for Conversion Rate of Convertible Notes	$1,000
Debt Conversion, Converted Instrument, Shares Issued	20.816
Debt Instrument, Convertible, Conversion Price	$48.04

Acquisition_Details_CyOptics_T

Acquisition (Details) CyOptics Textuals (USD $)

6 Months Ended

12 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

In Millions, unless otherwise specified

4-May-14

5-May-13

Nov. 03, 2013

4-May-14

Nov. 03, 2013

Order or Production Backlog [Member]

Customer Relationships [Member]

Purchased Technology - Packaging [Member]

Purchased Technology - Base Product [Member]

CyOptics Mexico [Member]

CyOptics [Member]

Minimum [Member]

employees

Purchased Technology - Base Product [Member]

CyOptics [Member]

Business Acquisition [Line Items]

Finite-Lived Intangible Asset, Useful Life

'1 year

'7 years

'5 years

'8 years

'1 year

Total Acquired Employees

745

1,100

Business Combination, Consideration Transferred

$377

Acquisitions, net of cash acquired

373

Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents

Business Acquisition, Contingent Consideration, Potential Cash Payment

Business Acquisition, Management Retention Bonus Prepayment

Business Acquisition, Management Retention Bonus Compensation

Business Acquisition, Purchase Price Allocation, Assets Acquired

$463

Acquisitions_Acquisition_CyOpt

Acquisitions Acquisition - CyOptics (Details) (USD $)	3 Months Ended	6 Months Ended	12 Months Ended
In Millions, unless otherwise specified	4-May-14	4-May-14	Nov. 03, 2013
Business Acquisition [Line Items]	'	'	'
Employee-related Liabilities, Current	($86)	($86)	($98)	[1]
Purchased Technology - Base Product [Member]	'	'	'
Business Acquisition [Line Items]	'	'	'
Acquired Finite-lived Intangible Asset, Amount	'	'	98
Finite-Lived Intangible Asset, Useful Life	'	'	'8 years
Purchased Technology - Packaging [Member]	'	'	'
Business Acquisition [Line Items]	'	'	'
Acquired Finite-lived Intangible Asset, Amount	'	'	3
Finite-Lived Intangible Asset, Useful Life	'	'	'5 years
Customer Relationships [Member]	'	'	'
Business Acquisition [Line Items]	'	'	'
Acquired Finite-lived Intangible Asset, Amount	'	'	32
Finite-Lived Intangible Asset, Useful Life	'	'	'7 years
Order or Production Backlog [Member]	'	'	'
Business Acquisition [Line Items]	'	'	'
Acquired Finite-lived Intangible Asset, Amount	'	'	4
Finite-Lived Intangible Asset, Useful Life	'	'	'1 year
CyOptics [Member]	'	'	'
Business Acquisition [Line Items]	'	'	'
Acquired Finite-lived Intangible Asset, Amount	'	'	137
CyOptics [Member]	'	'	'
Business Acquisition [Line Items]	'	'	'
Acquired Indefinite-lived Intangible Asset, Amount	'	'	4
CyOptics [Member]	'	'	'
Business Acquisition [Line Items]	'	'	'
Business Acquisition, Management Retention Bonus Compensation	1	10	'
Business Combination, Indemnification Assets, Amount as of Acquisition Date	12	12	'
Business Acquisition, Purchase Price Allocation, Current Assets, Receivables	'	'	51
Business Acquisition, Purchase Price Allocation, Current Assets, Inventory	'	'	35
Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets	'	'	2
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	'	'	44
Business Acquisition, Purchase Price Allocation, Goodwill Amount	'	'	190
Acquired Finite-lived Intangible Asset, Amount	'	'	141
Business Acquisition, Purchase Price Allocation, Assets Acquired	'	'	463
Business Acquisition, Purchase Price Allocation, Current Liabilities, Accounts Payable	'	'	-25
Business Acquisition, Purchase Price Allocation, Current Liabilities	'	'	-2
Business Acquisition, Purchase Price Allocation, Deferred Tax Liabilities, Noncurrent	'	'	-54
Business Acquisition, Purchase Price Allocation, Liabilities Assumed	'	'	-86
Business Combination, Consideration Transferred	'	'	377
Employee-related Liabilities, Current	'	'	($5)
CyOptics [Member] \| Purchased Technology - Base Product [Member]	'	'	'
Business Acquisition [Line Items]	'	'	'
Finite-Lived Intangible Asset, Useful Life	'	'	'8 years

[1]	Amounts as of NovemberÂ 3, 2013 have been derived from audited consolidated financial statements as of that date.

Acquisitions_Aquisition_CyOpti

Acquisitions Aquisition - CyOptics Pro Forma (Details) (CyOptics [Member], USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Nov. 03, 2013	Oct. 28, 2012
CyOptics [Member]	'	'
Business Acquisition [Line Items]	'	'
Business Acquisition, Pro Forma Revenue	$2,663	$2,578
Business Acquisition, Pro Forma Net Income (Loss)	$547	$551
Business Acquisition, Pro Forma Earnings Per Share, Basic	$2.21	$2.25
Business Acquisition, Pro Forma Earnings Per Share, Diluted	$2.17	$2.20

Acquisitions_Acquisitions_and_

Acquisitions Acquisitions and Investment (Details) (USD $)	6 Months Ended
In Millions, unless otherwise specified	5-May-13
Investment [Line Items]	'
Amount previously paid for Trading Securities Held-for-investment	$9

Goodwill_and_Intangible_Assets2

Goodwill and Intangible Assets (Details 1) (USD $)	4-May-14	Nov. 03, 2013
In Millions, unless otherwise specified	4-May-14	Nov. 03, 2013
Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]	'	'
Finite-Lived Intangible Assets, Gross	$1,140	$1,140
Finite Lived Intangible Assets Net [Abstract]	'	'
Intangible Assets, Net Excluding Goodwill	441	492	[1]
Finite-Lived Intangible Assets, Accumulated Amortization	703	652
Finite-Lived Intangible Assets, Net	437	488
Intangible Assets, Gross (Excluding Goodwill)	1,144	1,144
In Process Research and Development [Member]	'	'
Finite Lived Intangible Assets Net [Abstract]	'	'
Indefinite-Lived Intangible Assets (Excluding Goodwill)	4	4
Technology-Based Intangible Assets [Member]	'	'
Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]	'	'
Finite-Lived Intangible Assets, Gross	843	843
Finite Lived Intangible Assets Net [Abstract]	'	'
Finite-Lived Intangible Assets, Accumulated Amortization	498	462
Finite-Lived Intangible Assets, Net	345	381
Customer And Distributor Relationships [Member]	'	'
Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]	'	'
Finite-Lived Intangible Assets, Gross	289	289
Finite Lived Intangible Assets Net [Abstract]	'	'
Finite-Lived Intangible Assets, Accumulated Amortization	199	186
Finite-Lived Intangible Assets, Net	90	103
Other Intangible Assets [Member]	'	'
Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]	'	'
Finite-Lived Intangible Assets, Gross	8	8
Finite Lived Intangible Assets Net [Abstract]	'	'
Finite-Lived Intangible Assets, Accumulated Amortization	6	4
Finite-Lived Intangible Assets, Net	$2	$4

[1]	Amounts as of NovemberÂ 3, 2013 have been derived from audited consolidated financial statements as of that date.

Recovered_Sheet1

Goodwill And Intangible Assets (Details 2) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	4-May-14	5-May-13	4-May-14	5-May-13
Amortization of purchased intangible assets	'	'	'	'
Cost of Goods Sold, Amortization	$18	$14	$36	$28
Amortization of intangible assets	8	6	15	11
Total Amortization	$26	$20	$51	$39

Goodwill_and_Intangible_Assets3

Goodwill and Intangible Assets (Details 3) (USD $)	4-May-14	Nov. 03, 2013
In Millions, unless otherwise specified	4-May-14	Nov. 03, 2013
Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]	'	'
Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year	$49	'
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	95	'
Finite-Lived Intangible Assets, Amortization Expense, Year Two	78	'
Finite-Lived Intangible Assets, Amortization Expense, Year Three	68	'
Finite-Lived Intangible Assets, Amortization Expense, Year Four	33	'
Finite-Lived Intangible Assets, Amortization Expense, Year Five	29	'
Finite-Lived Intangible Assets, Amortization Expense, after Year Five	85	'
Finite-Lived Intangible Assets, Net	$437	$488

Goodwill_and_Intangible_Assets4

Goodwill and Intangible Assets (Details 4)	6 Months Ended
Goodwill and Intangible Assets (Details 4)	4-May-14
Technology-Based Intangible Assets [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	'7 years
Customer And Distributor Relationships [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	'6 years
Other Intangible Assets [Member]	'
Acquired Finite-Lived Intangible Assets [Line Items]	'
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	'13 years

Retirement_Plans_and_PostRetir1

Retirement Plans and Post-Retirement Benefits (Details) (USD $)	6 Months Ended
	4-May-14	Nov. 03, 2013
Defined Benefit Plan Disclosure [Line Items]	'	'
Payments to Employees	$6,000,000	'
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]	'	'
Curtailment gain	1,000,000	'
Settlement Gain	2,000,000	'
U.S. Post-Retirement Medical Benefit Plan [Member]	'	'
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]	'	'
Pension and Other Postretirement Defined Benefit Plans, Liabilities	14,000,000	'
Retiree medical account program, spending account $55,000 [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Postretirement medical account program, spending account, amount	55,000	'
Retiree medical account program, spending account of $40,000 [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Postretirement medical account program, spending account, amount	40,000	'
KOREA, REPUBLIC OF	'	'
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]	'	'
Defined Benefit Plan, Settlements, Plan Assets	7,000,000	'
Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent	'	5,000,000
KOREA, REPUBLIC OF \| Defined Contribution Pension [Member]	'	'
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]	'	'
Pension and Other Postretirement Benefit Contributions	$2,000,000	'

Borrowings_Details

Borrowings (Details) (USD $)	4-May-14	Nov. 03, 2013	4-May-14	6-May-14	6-May-14	6-May-14
			Line of Credit [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]
					LSI acquisition [Member]	Maximum [Member]
Debt Instrument [Line Items]	'	'	'	'	'	'
Line of Credit Facility, Maximum Borrowing Capacity	'	'	$575,000,000	$6,700,000,000	'	$500,000,000
Line of Credit Facility, Amount Outstanding	0	0	'	'	'	'
Expected financing through term loans for transaction	'	'	'	'	4,600,000,000	'
Proceeds from Convertible Debt	'	'	'	'	1,000,000,000	'
Debt Issuance Cost	2,000,000	'	'	'	'	'
Prepaid Expense Other, Noncurrent	$5,000,000	'	'	'	'	'

Fair_Value_Details

Fair Value (Details) (Fair Value, Measurements, Recurring [Member], USD $)	4-May-14
In Millions, unless otherwise specified	4-May-14
Portion of Carrying Value Measured at Fair Value [Member]	'
Liabilities	'
Liabilities measured at fair value	$12	[1]
Fair Value Measurement Using Quoted Prices In Active Market For Identical Assets (Level 1) [Member]	'
Assets	'
Deferred Compensation Plan Assets	12	[2]
Bank acceptances	1	[2]
Assets measured at fair value	13
Liabilities	'
Liabilities measured at fair value	0
Fair Value Measurement Using Significant Other Inputs [Member]	'
Assets	'
Deferred Compensation Plan Assets	0
Bank acceptances	0
Assets measured at fair value	0
Liabilities	'
Liabilities measured at fair value	12	[1]
Fair Value Measurement Using Unobservable Inputs	'
Assets	'
Deferred Compensation Plan Assets	0
Bank acceptances	0
Assets measured at fair value	0
Liabilities	'
Liabilities measured at fair value	$0

[1]	Included in other current liabilities in our unaudited condensed consolidated balance sheet
[2]	Included in other current assets in our unaudited condensed consolidated balance sheet

Fair_Value_Details_Textuals

Fair Value (Details Textuals) (USD $)	4-May-14
In Millions, unless otherwise specified	4-May-14
Fair Value, Measurements, Recurring [Member] \| Level 1 [Member]	'
Fair Value (Textuals) [Abstract]	'
Non-financial assets measured at fair value	$13
Non-financial liabilities measured at fair value	0
Fair Value, Measurements, Recurring [Member] \| Fair Value Measurement Using Unobservable Inputs	'
Fair Value (Textuals) [Abstract]	'
Non-financial assets measured at fair value	0
Non-financial liabilities measured at fair value	0
Fair Value, Measurements, Nonrecurring [Member]	'
Fair Value (Textuals) [Abstract]	'
Non-financial assets measured at fair value	0
Non-financial liabilities measured at fair value	$0

Shareholders_Equity_Share_Repu

Shareholders' Equity (Share Repurchase Program and Dividends) (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, except Per Share data, unless otherwise specified	4-May-14	5-May-13	4-May-14	5-May-13	Apr. 09, 2014
Shareholders Equity (Textuals) [Abstract]	'	'	'	'	'
Stock Repurchase Program, Number of Maximum Shares Authorized to be Repurchased with Additional Board Approval	'	'	'	'	25
Cash dividend paid, per share	$0.27	$0.19	'	'	'
Payments of Ordinary Dividends, Ordinary Shares	$68	$47	$130	$89	'
2013 Share Repurchase Plan [Member]	'	'	'	'	'
Shareholders Equity (Textuals) [Abstract]	'	'	'	'	'
Stock Repurchased, shares	'	'	0.3	'	'
Repurchase of shares in cash	'	'	$12	'	'
Weighted average price per share	'	'	$43.50	'	'

Shareholders_Equity_Share_Base

Shareholders' Equity (Share Based Compensation Expense) (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	4-May-14	5-May-13	4-May-14	5-May-13
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Allocated share-based compensation expense	$30	$17	$54	$35
Cost of Products Sold [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Allocated share-based compensation expense	3	2	6	4
Research and Development [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Allocated share-based compensation expense	10	7	18	14
Selling, General and Administrative [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Allocated share-based compensation expense	$17	$8	$30	$17

Shareholders_Equity_WeightedAv

Shareholders' Equity (Weighted-Average Assumptions) (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, except Per Share data, unless otherwise specified	4-May-14	5-May-13	4-May-14	5-May-13
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$32	$19	$42	$27
Number of Outstanding Options	27	'	27	'
Weighted Average Remaining Contractual Term in years	'	'	'5 years 7 months 25 days	'
Employee Stock Option [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$16.04	$12.53	$15.56	$12.65
Weighted average assumptions of share-based payment awards	'	'	'	'
Risk-free interest rate	1.30%	0.90%	1.30%	0.90%
Dividend yield	1.70%	1.90%	1.80%	1.90%
Volatility	35.00%	48.00%	35.00%	49.00%
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	230	'	230	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'4 years 3 months 20 days	'5 years	'4 years 2 months 13 days	'5 years
Market Based Options [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$22.33	$13.34	$20.79	$13.34
Weighted average assumptions of share-based payment awards	'	'	'	'
Risk-free interest rate	2.30%	1.40%	2.30%	1.40%
Dividend yield	1.70%	1.90%	1.80%	1.90%
Volatility	45.00%	50.00%	45.00%	50.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'7 years	'7 years	'7 years	'7 years
Employee Stock Purchase Plan [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$14.61	$11.73	$13.44	$11.63
Weighted average assumptions of share-based payment awards	'	'	'	'
Risk-free interest rate	0.10%	0.10%	0.10%	0.10%
Dividend yield	1.70%	2.10%	2.00%	2.00%
Volatility	31.00%	46.00%	34.00%	45.00%
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	1	'	1	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'6 months	'6 months	'6 months	'6 months
Restricted Stock Units (RSUs) [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value	12	1	13	1
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$62.06	$35.46	$59.02	$35.34
Weighted average assumptions of share-based payment awards	'	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	$62	'	$62	'
Restricted Stock [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	'	'	$59.03	'
0.00-10.00 [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Number of Outstanding Options	1	'	1	'
Weighted Average Remaining Contractual Term in years	'	'	'4 years 22 days	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$8.47	'	$8.47	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$8.49	'	$8.49	'
10.01-20.00 [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Number of Outstanding Options	2	'	2	'
Weighted Average Remaining Contractual Term in years	'	'	'4 years 6 months 20 days	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$13.31	'	$13.31	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$13.33	'	$13.33	'
20.01-30.00 [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Number of Outstanding Options	2	'	2	'
Weighted Average Remaining Contractual Term in years	'	'	'6 years 1 month 28 days	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$21	'	$21	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$20.86	'	$20.86	'
30.01-40.00 [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Number of Outstanding Options	15	'	15	'
Weighted Average Remaining Contractual Term in years	'	'	'5 years 4 months 2 days	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$35.48	'	$35.48	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$34.19	'	$34.19	'
40.01-50.00 [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Number of Outstanding Options	1	'	1	'
Weighted Average Remaining Contractual Term in years	'	'	'6 years 5 months 18 days	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$45.56	'	$45.56	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$0	'	$0	'
50.01-60.00 [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Number of Outstanding Options	1	'	1	'
Weighted Average Remaining Contractual Term in years	'	'	'6 years 8 months 9 days	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$53.57	'	$53.57	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$0	'	$0	'
60.01-63.18 [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Number of Outstanding Options	5	'	5	'
Weighted Average Remaining Contractual Term in years	'	'	'6 years 10 months 1 day	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$62.01	'	$62.01	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$0	'	$0	'

Shareholders_Equity_Share_Base1

Shareholders' Equity (Share Based Compensation Expense) (Details Textuals) (USD $)	3 Months Ended		6 Months Ended
In Millions, except Per Share data, unless otherwise specified	4-May-14	5-May-13	4-May-14	5-May-13
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Expected Life Of Options And Implied Volatility Description	'	'	'For the two fiscal quarters ended MayÂ 4, 2014, expected volatility for time-based and market-based options is based on our own historical share price volatility and or combining historical volatility of guideline publicly traded companies and our own historical share price volatility over the period commensurate with the expected life of the awards and the implied volatility from our own traded shares with a term of 180Â days measured at a specific date. Prior to fiscal year 2014, expected volatility was based on the combination of historical volatility of guideline publicly-traded companies and our own historical share price volatility over the period commensurate with the expected life of the awards and the implied volatility from traded options in guideline publicly-traded companies and our own shares with a term of 720Â days or greater measured over the last three months.	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$32	$19	$42	$27
Employee Stock Option [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition	'	'	'3 years	'
Weighted-average fair values of options granted	$16.04	$12.53	$15.56	$12.65
Total compensation cost related to unvested options	230	'	230	'
Employee Stock Purchase Plan [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Total compensation cost related to unvested options	1	'	1	'
Restricted Stock Units (RSUs) [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	'	'	$39.04	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition	'	'	'3 years	'
Total compensation cost related to unvested options	62	'	62	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value	$12	$1	$13	$1

Shareholders_Equity_Equity_Inc

Shareholders' Equity (Equity Incentive Award Plans) (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, except Per Share data, unless otherwise specified	4-May-14	5-May-13	4-May-14	5-May-13	Nov. 03, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'
Number of Outstanding Options	27	'	27	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value	$46	$17	$69	$42	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]	'	'	'	'	'
Number Outstanding, Beginning Balance	'	'	22	'	'
Weighted-Average Exercise Price Per Share, Beginning Balance	'	'	$29.81	'	'
Annual increase, Awards Available for Grant	'	'	6	'	'
Share Based Compensation Arrangement By Share Based Payment Award Shares Granted From Shares Available For Grant	'	'	7	'	'
Granted, Number Outstanding	'	'	7	'	'
Granted, Weighted-Average Exercise Price Per Share	'	'	$59.56	'	'
Exercised, Number Outstanding	'	'	-2	'	'
Exercised, Weighted-Average Exercise Price Per Share	'	'	$24.28	'	'
Share Based Compensation Arrangement By Share Based Payment Award Shares Cancelled From Shares Available For Grant	'	'	0	'	'
Cancelled, Number Outstanding	'	'	0	'	'
Cancelled, Weighted-Average Exercise Price Per Share	'	'	$36.67	'	'
Weighted-Average Exercise Price Per Share, Ending Balance	$37.82	'	$37.82	'	'
Weighted Average Remaining Contractual Term in years	'	'	'5 years 7 months 25 days	'	'
Aggregate Intrinsic Value, Ending Balance	705	'	705	'	'
Vested, Number Outstanding	8	'	8	'	'
Vested, Weighted-Average Exercise Price Per Share	$23.70	'	$23.70	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	'	'	'4 years 9 months 26 days	'	'
Vested, Aggregate Intrinsic Value	339	'	339	'	'
Vested and expected to vest, Number Outstanding	25	'	25	'	'
Vested and expected to vest, Weighted-Average Exercise Price Per Share	$37.14	'	$37.14	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term	'	'	'5 years 7 months 10 days	'	'
Vested and expected to vest, Aggregate Intrinsic Value	$682	'	$682	'	'
Restricted Stock Units (RSUs) [Member]	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	2	'	2	'	2
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$43.05	'	$43.05	'	$34.38
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	'	'	1	'	'
Weighted-average fair value, other than options	$62.06	$35.46	$59.02	$35.34	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	'	'	-1	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	'	'	$33.89	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	'	'	0	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	'	'	$39.04	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	'	'	'3 years 1 month 28 days	'	'
Employee Stock Option [Member]	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$16.04	$12.53	$15.56	$12.65	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]	'	'	'	'	'
Awards Available for Grant, Beginning Balance	'	'	10	'	'
Awards Available for Grant, Ending Balance	9	'	9	'	'
Market Based Options [Member]	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$22.33	$13.34	$20.79	$13.34	'

Shareholders_Equity_Significan

Shareholders' Equity (Significant Ranges of Outstanding and Exercisable Awards) (Details) (USD $)	6 Months Ended
In Millions, except Per Share data, unless otherwise specified	4-May-14	Nov. 03, 2013
Ranges of outstanding and exercisable awards	'	'
Number of Outstanding Options	27	'
Weighted Average Remaining Contractual Term in years	'5 years 7 months 25 days	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$37.82	$29.81
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	8	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$23.70	'
0.00-10.00 [Member]	'	'
Ranges of outstanding and exercisable awards	'	'
Exercise Prices, Minimum	$0	'
Exercise Prices, Maximum	$10	'
Number of Outstanding Options	1	'
Weighted Average Remaining Contractual Term in years	'4 years 22 days	'
Weighted-Average Exercise Price Per Share for outstanding options	$8.47	'
Number of Exercisable Options	1	'
Weighted-Average Exercise Price Per Share for exercisable options	$8.49	'
10.01-20.00 [Member]	'	'
Ranges of outstanding and exercisable awards	'	'
Exercise Prices, Minimum	$10.01	'
Exercise Prices, Maximum	$20	'
Number of Outstanding Options	2	'
Weighted Average Remaining Contractual Term in years	'4 years 6 months 20 days	'
Weighted-Average Exercise Price Per Share for outstanding options	$13.31	'
Number of Exercisable Options	2	'
Weighted-Average Exercise Price Per Share for exercisable options	$13.33	'
20.01-30.00 [Member]	'	'
Ranges of outstanding and exercisable awards	'	'
Exercise Prices, Minimum	$20.01	'
Exercise Prices, Maximum	$30	'
Number of Outstanding Options	2	'
Weighted Average Remaining Contractual Term in years	'6 years 1 month 28 days	'
Weighted-Average Exercise Price Per Share for outstanding options	$21	'
Number of Exercisable Options	1	'
Weighted-Average Exercise Price Per Share for exercisable options	$20.86	'
30.01-40.00 [Member]	'	'
Ranges of outstanding and exercisable awards	'	'
Exercise Prices, Minimum	$30.01	'
Exercise Prices, Maximum	$40	'
Number of Outstanding Options	15	'
Weighted Average Remaining Contractual Term in years	'5 years 4 months 2 days	'
Weighted-Average Exercise Price Per Share for outstanding options	$35.48	'
Number of Exercisable Options	4	'
Weighted-Average Exercise Price Per Share for exercisable options	$34.19	'
40.01-50.00 [Member]	'	'
Ranges of outstanding and exercisable awards	'	'
Exercise Prices, Minimum	$40.01	'
Exercise Prices, Maximum	$50	'
Number of Outstanding Options	1	'
Weighted Average Remaining Contractual Term in years	'6 years 5 months 18 days	'
Weighted-Average Exercise Price Per Share for outstanding options	$45.56	'
Number of Exercisable Options	0	'
Weighted-Average Exercise Price Per Share for exercisable options	$0	'
50.01-60.00 [Member]	'	'
Ranges of outstanding and exercisable awards	'	'
Exercise Prices, Minimum	$50.01	'
Exercise Prices, Maximum	$60	'
Number of Outstanding Options	1	'
Weighted Average Remaining Contractual Term in years	'6 years 8 months 9 days	'
Weighted-Average Exercise Price Per Share for outstanding options	$53.57	'
Number of Exercisable Options	0	'
Weighted-Average Exercise Price Per Share for exercisable options	$0	'
60.01-63.18 [Member]	'	'
Ranges of outstanding and exercisable awards	'	'
Exercise Prices, Minimum	$60.01	'
Exercise Prices, Maximum	$63.18	'
Number of Outstanding Options	5	'
Weighted Average Remaining Contractual Term in years	'6 years 10 months 1 day	'
Weighted-Average Exercise Price Per Share for outstanding options	$62.01	'
Number of Exercisable Options	0	'
Weighted-Average Exercise Price Per Share for exercisable options	$0	'

Shareholders_Equity_Employee_S

Shareholders' Equity (Employee Share Purchase Plan) (Details)	6 Months Ended
In Millions, unless otherwise specified	4-May-14	5-May-13
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Stock Issued During Period, Shares, Employee Stock Purchase Plans	0.1	0.1
Employee Stock [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Shares available for issuance under the ESPP	9.2	'

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	4-May-14	5-May-13	4-May-14	5-May-13	Feb. 02, 2014	Nov. 03, 2013
Income Tax Contingency [Line Items]	'	'	'	'	'	'
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations	$10	'	$14	'	'	'
Provision for income taxes	1	5	6	6	'	'
Deferred Charge, Current	'	'	'	'	4	'
Deferred Charge, Non-Current	'	'	'	'	28	'
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	'	'	'	'	'	35
Tax benefit, reinstatement of research and development tax credits	'	'	'	3	'	'
Deferred Charge, Total	'	'	'	'	32	'
Maximum [Member]	'	'	'	'	'	'
Income Tax Contingency [Line Items]	'	'	'	'	'	'
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations	'	'	$3	'	'	'

Segment_Information_Details

Segment Information (Details)	6 Months Ended
Segment Information (Details)	4-May-14
Segment Reporting Information [Line Items]	'
Number of Reportable Segments	1

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)

3 Months Ended

6 Months Ended

0 Months Ended

4-May-14

5-May-13

4-May-14

5-May-13

Nov. 03, 2013

6-May-14

Subsequent Event [Member]

Convertible Debt [Member]

LSI acquisition [Member]

Subsequent Event [Member]

LSI acquisition [Member]

Related Party Transaction [Line Items]

Revenue from Related Parties

$10,000,000

[1],[2]

$16,000,000

[1],[2]

Costs and operating expenses, less than $0.5 million as of February 2, 2014

[3]

1,000,000

[2]

[3]

2,000,000

[2]

Receivables

[3]

Payables, less than $0.5 million as of November 3, 2013 and February 2, 2014, respectively

[3]

Proceeds from Convertible Debt

$1,000,000,000

Debt Instrument, Interest Rate, Stated Percentage

2.00%

[1]

Amounts include net revenue for related party transactions with Wistron Corporation through the fiscal quarter ended MayÂ 5, 2013. Wistron Corporation ceased to be a related party after the fiscal quarter ended AugustÂ 4, 2013.

[2]

Amounts include net revenue, cost and expenses for related party transactions with eSilicon Corporation through the fiscal quarter ended MayÂ 5, 2013. eSilicon Corporation ceased to be a related party after the fiscal quarter MayÂ 5, 2013.

[3]

Represent amounts less than $0.5 million.

Recovered_Sheet2

Commitments and Contingencies (Details) (USD $)	4-May-14
In Millions, unless otherwise specified	4-May-14
Purchase and Other Contractual Commitments	'
Purchase Commitments, Total	$216
Purchase Commitments, 2014 (remainder)	216
Purchase Commitments, 2015	0
Purchase Commitments, 2016	0
Purchase Commitments, 2017	0
Purchase Commitments, 2018	0
Purchase Commitments, 2019	0
Purchase Commitments, Thereafter	0
Other Contractual Commitments, Total	50
Other Contractual Commitments, 2014 (remainder)	11
Other Contractual Commitments, 2015	16
Other Contractual Commitments, 2016	13
Other Contractual Commitments, 2017	6
Other Contractual Commitments, 2018	4
Other Contractual Commitments, 2019	0
Other Contractual Commitments, Thereafter	0
Fort Collins Internal Fab Facility [Member]	'
Unrecorded Unconditional Purchase Obligation [Line Items]	'
Purchase Obligation	$67

Restructuring_charges_Details

Restructuring charges (Details) (USD $)	6 Months Ended
In Millions, unless otherwise specified	4-May-14	Nov. 03, 2013
Restructuring Cost and Reserve [Line Items]	'	'
Restructuring and Related Cost, Number of Positions Eliminated	120	'
Payments for Restructuring	$5	'
Restructuring and Related Cost, Expected Cost Remaining	18	0
Other Noncash Expense	2	'
Operating Expenses [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Employee termination costs	6	'
Cost of Products Sold [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Severance Costs	5	'
Business Exit Costs	0	'
Restructuring and Related Cost, Incurred Cost	5	'
Other Restructuring Costs	0	'
Selling, General and Administrative Expenses [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Severance Costs	17	'
Business Exit Costs	2	'
Restructuring and Related Cost, Incurred Cost	20	'
Other Restructuring Costs	1	'
One-time Termination Benefits [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Payments for Restructuring	4	'
Other Noncash Expense	0	'
Employee Severance [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Restructuring and Related Cost, Expected Cost Remaining	18	'
Employee Severance [Member] \| Operating Expenses [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Restructuring and Related Cost, Cost Incurred to Date	8	'
Employee Severance [Member] \| Cost of Products Sold [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Restructuring and Related Cost, Cost Incurred to Date	5	'
Facility Closing [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Payments for Restructuring	0	'
Restructuring and Related Cost, Expected Cost Remaining	0	0
Other Noncash Expense	2	'
Facility Closing [Member] \| Operating Expenses [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Business Exit Costs	1	'
Operating Expenses [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Restructuring and Related Cost, Expected Cost	8	'
Operating Expenses [Member] \| Research and Development Expense [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Restructuring and Related Cost, Cost Incurred to Date	5	'
Other Expense [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Restructuring and Related Cost, Expected Cost	4	'
Payments for Restructuring	1	'
Other Noncash Expense	0	'
Other Restructuring [Member]	'	'
Restructuring Cost and Reserve [Line Items]	'	'
Restructuring and Related Cost, Expected Cost Remaining	$0	'

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Income (Loss) (Details) (USD $)	3 Months Ended		6 Months Ended
	4-May-14	5-May-13	4-May-14	5-May-13	Nov. 03, 2013
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'
Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax	($7,000,000)	'	($7,000,000)	'	($6,000,000)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	'	'	1,000,000	'	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	3,000,000	'	'	'	'
Other income, net	0	1,000,000	0	3,000,000	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	0	0	-3,000,000	0	'
Other Comprehensive Income (Loss), Tax	'	'	1,000,000	'	'
Other Comprehensive Income (Loss), Net of Tax	0	2,000,000	-1,000,000	4,000,000	'
prior service cost [Member]	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'
Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax	-1,000,000	'	-1,000,000	'	-1,000,000
Other Comprehensive Income (Loss), before Reclassifications, before Tax	'	'	1,000,000	'	'
Other Comprehensive Income (Loss), Tax	'	'	0	'	'
Other Comprehensive Income (Loss), Net of Tax	'	'	0	'	'
prior service cost [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	'	'	-1,000,000	'	'
Actuarial G/L [Member]	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'
Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax	-6,000,000	'	-6,000,000	'	-5,000,000
Other Comprehensive Income (Loss), before Reclassifications, before Tax	'	'	0	'	'
Other Comprehensive Income (Loss), Tax	'	'	1,000,000	'	'
Other Comprehensive Income (Loss), Net of Tax	'	'	-1,000,000	'	'
Actuarial G/L [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	-2,000,000	'	'	'	'
Selling, General and Administrative Expenses [Member]	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Plans, before tax	0	0	1,000,000	0	'
Research and Development Expense [Member]	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Plans, before tax	0	0	1,000,000	0	'
Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Plans, before tax	$0	$0	$1,000,000	$0	'

Subsequent_Events_Details

Subsequent Events (Details) (Subsequent Event [Member], USD $)	0 Months Ended			6 Months Ended
	29-May-14	13-May-14	6-May-14	4-May-14	Jun. 04, 2014
	29-May-14	employees	6-May-14	4-May-14	Jun. 04, 2014
Subsequent Event [Line Items]	'	'	'	'	'
Line of credit facility, remaining borrowing capacity	'	'	$6,700,000,000	'	'
Secured loan, term	'	'	'7 years	'	'
Line of credit, covenant compliance, draw down percentage	'	'	30.00%	'	'
Line of credit facility, current borrowing capacity	'	'	5,100,000,000	'	'
Restructuring and related cost, expected number of positions eliminated	'	1,100	'	'	'
Pending Sale of LSI Flash Component and Accelerated Solutions Divisions	450,000,000	'	'	'	'
Common Stock dividend declared date	'	'	'	4-Jun-14	'
Interim cash dividend per share	'	'	'	'	$0.29
Dividends payable, date to be paid	'	'	'	30-Jun-14	'
Common Stock dividend record date	'	'	'	19-Jun-14	'
LSI acquisition [Member]	'	'	'	'	'
Subsequent Event [Line Items]	'	'	'	'	'
Preliminary purchase price related to LSI acquisition	'	'	6,500,000,000	'	'
Share price per share of LSI common stock	'	'	$11.15	'	'
Proceeds from issuance of convertible debt	'	'	1,000,000,000	'	'
Expected financing through term loans for transaction	'	'	4,600,000,000	'	'
Business Acquisition-Cash on hand	'	'	1,000,000,000	'	'
Convertible debt, conversion ratio	'	'	20.816	'	'
Principal amount basis for conversion rate of convertible notes	'	'	1,000	'	'
Convertible debt, conversion price	'	'	$48.04	'	'
Swingline Loan	'	'	75,000,000	'	'
Letter of Credit [Member]	'	'	'	'	'
Subsequent Event [Line Items]	'	'	'	'	'
Line of credit facility, remaining borrowing capacity	'	'	100,000,000	'	'
Maximum [Member]	'	'	'	'	'
Subsequent Event [Line Items]	'	'	'	'	'
Line of credit facility, remaining borrowing capacity	'	'	$500,000,000	'	'
Revolving Credit Facility [Member]	'	'	'	'	'
Subsequent Event [Line Items]	'	'	'	'	'
Secured loan, term	'	'	'5 years	'	'
US Federal Funds Rate [Member]	'	'	'	'	'
Subsequent Event [Line Items]	'	'	'	'	'
Basis spread on variable rate	'	'	0.50%	'	'
London Interbank Offered Rate (LIBOR) [Member]	'	'	'	'	'
Subsequent Event [Line Items]	'	'	'	'	'
Basis spread on variable rate	'	'	1.00%	'	'
London Interbank Offered Rate (LIBOR) [Member] \| Term Loan [Member]	'	'	'	'	'
Subsequent Event [Line Items]	'	'	'	'	'
Basis spread on variable rate	'	'	1.75%	'	'
LIBO rate interest period multiplier	'	'	0.0075	'	'
Convertible Debt [Member] \| LSI acquisition [Member]	'	'	'	'	'
Subsequent Event [Line Items]	'	'	'	'	'
Interest rate, stated percentage	'	'	2.00%	'	'
Dividend threshold for adjustment of conversion price	'	'	$0.27	'	'
Percentage of principal amount available to be called upon fundamental change	'	'	100.00%	'	'
Minimum number of trading days in which redemption exceeds conversion price	'	'	'20 days	'	'
Number of consecutive trading days	'	'	'30 days	'	'
Minimum percentage of conversion price	'	'	150.00%	'	'